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ABSTRACT
A STUDY OF THE MOLECULES INVOLVED IN THE REGULATION OF THE GROWTH OF HAEMATOPOIETIC CELLS AND HEART MUSCLE CELLS 
IN CULTURE
WILLIAM SAMUEL GILMORE
The description of the molecular events responsible for the control of cell division and differentiation is, 
currently, one of the major goals of molecular and cellular biologists. Cell and tissue culture techniques have proved to be promising laboratory tools for the study of the 
regulators of cellular growth and differentiation. Most cells in culture require specific polypeptide growth factors which are supplied by the addition of a complex
biological fluid such as serum or, in some instances, bythe cells themselves. These growth factors usually act on their target cell via a membrane receptor to which they 
bind.The events which occur after the growth factor binds to the membrane receptor have not been fully described, but the phosphorylation of tyrosine residues in certain
proteins has been observed.A study was made of the polypeptide growth factors responsible for the growth and differentiation of
haematopoietic cells in vitro . These growth factors,called colony - stimulating factors (C.S.F.'s) were prepared from human placental conditioned medium, giant 
cell tumour conditioned medium and pokeweed mitogenstimulated spleen conditioned medium. A C.S.F, from human
placental conditioned medium was radioiodinated and the
binding of the labelled growth factor to an anti-C.S.F. antiserum was studied. The binding studies indicated that a purer C.S.F. preparation and/or a more specific antiserum 
was necessary in order to establish a radioimmunoassay forC.S.F. The C.S.F.*s from giant cell tumour conditioned medium were purified by ultrafiltration, hydrophobic - 
interaction chromatography, gel filtration and thiolpropyl - sepharose 6B chromatography. Two peaks of biological activity were observed on gel filtration. One of these 
peaks gave an apparent MW of 63,000 and the other peak gave an apparent MW of 30,200. The C.S.F. from pokeweed mitogen 
stimulated spleen conditioned medium was labelled with 
peroxidase and the binding of the labelled-C.S.F. to bone marrow cell membranes studied. The labelled-C.S.F. bound to 
the membranes and the binding exhibited a linear 
relationship with membrane protein content. Also,a defined growth medium for chick embryonic heart cells was developed. These cells were observed to differentiate from 
primitive foetal cells into mature "adult-type" cells. The cells grew as a monolayer, had spontaneous activity and 
were seen to beat.
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GENERAL INTRODUCTION
INTRODUCTION
One of the major challenges in biochemistry is the 
description of the molecular events responsible for the 
control of cell proliferation and differentiation. The 
first detailed description of the various stages of cell 
division was given by Schneider in 1873. In 1875 
Strassburger published the first monograph on cell division 
and in 1882 Flemming named the complete process 
karyomitosisC” a threadlike metamorphosis of the nucleus).
We now know that mitosis is governed by other events 
which take place in the cell cycle.After mitosis (M-phase) 
the cells undergo a period of growth (Gl-phase) followed by 
a period of DNA synthesis (S-phase). A second period of 
growth (G2-phase) in which the cells prepare for mitosis 
follows S-phase. The cells may remain for long periods of 
time in a resting phase (GO-phase) or they may enter 
Gl-phase and cycle again. For a review see Paweletz and 
Little (1980).
The study of cell proliferation has been 
facilitated by the introduction of cell culture techniques 
(Paul 1972). The growth and maintenance of cells in 
culture requires the presence of nutrients, usually in the 
form of a defined tissue culture medium (Waymouth, 1972). 
Serum is required by most mammalian cell lines in culture. 
The components of serum necessary for the maintenance and 
growth of cells lu vitro have not been fully identified
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(Ternin e^ al^  , 1972). However, serum has been replaced 
by hormones and transferrin to permit the growth of a rat 
pituitary cell line (Hayashi and Sato, 1976) and the growth 
of erythroid colonies iu vitro has been demonstrated in 
conditions where the serum concentration has been lowered 
and selenite, transferrin, albumin and lecithin included in 
the tissue culture medium. (Guilbert and Iscove, 1976). 
Serum-free cell culture has been developed for a number of 
cell lines so permitting their growth in a defined medium 
(Barnes and Sato, 1980a; Barnes and Sato, 1980b).
In the present study serum-free cell culture was 
developed for the growth and differentiation of chick 
myocardial cells. The medium consisted of Leibowitz L-15 
tissue culture medium with added transferrin, albumin, 
phosphatidyl choline, glucagon, insulin, somatotropin, 
sodium pyruvate and sodium selenite.
Macromolecules responsible for the growth and 
maintenance of cells in culture have been recognised for 
some time. These growth factors include; nerve growth 
factor, epidermal growth factor, fibroblast growth factor, 
multiplication stimulating activity, insulin-like growth 
factors, platelet-derived growth factor, interleukin-2 , 
interleukin-3, B-cell growth factor, thrombopoietin, 
erythropoietin and colony - stimulating factor 
(Gospodarowicz and Moran, 1976; James and Bradshaw, 1984).
Nerve growth factor was first described in 1954 (Cohen 
et al ). This protein stimulates nerve cells to divide 
and differentiate. Nerve growth factor is present in a 
large number of tissues but the richest source is the male 
mouse submaxillary gland. The molecule is present in the 
submaxillary gland as a complex protein of 130,000 
molecular weight and a sub-unit structure of • The 0
sub-unit possesses all of the biological activity and is 
composed of two identical polypeptide chains of 13,259 
molecular weight. It has been proposed that nerve growth 
factor binds to plasma membrane receptors and 
internalisation takes place. The internalised nerve growth 
factor is thought to be transported to the nucleus where a
D.N.A. template is uncovered and gene activity directly 
influenced. For a review see Bradshaw (1978).
Epidermal Growth factor was isolated from the mouse 
submaxillary gland during the early studies on nerve growth 
factor (Cohen, 1959). Epidermal growth factor stimulates 
the proliferation of epidermal cells in culture. Epidermal 
growth factor is a polypeptide with a molecular weight of 
6,100. Cells responsive to epidermal growth factor possess 
membrane receptors to which the factor binds. The epidermal 
growth factor is then internalised. The sequence of events 
which occur after internalisation of the growth factor is 
unclear. However epidermal growth factor stimulates the 
phosphorylation of tyrosine residues of membrane bound 
proteins in epidermal growth factor acitivated cells. 
(Ushiro and Cohen, 1980). For a review of epidermal growth
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factor see Carpenter and Cohen (1979).
The first haematopoietic growth factor to be 
recognised was erythropoietin, the stimulator of 
erythropoiesis (Camot and De f land re, 1906) Other 
haematopoietic growth factors include; interleukin-3 which 
stimulates the early stem cells, interleukin-2 which 
stimulates the production of T-lymphocytes, B-cell growth 
factor, thrombopoietin which stimulates platelet production 
and the colony-stimulating factors which stimulate the 
growth of granulocytes, monocytes and eosinophils in 
culture (Table 1).
The haematopoietic system consists of cells which are 
continuously dividing and differentiating. These cells are 
readily accessible for study in the laboratory and 
haematopoiesis provides a model for the investigation of 
cell proliferation.Early descriptions of haematopoiesis 
relied on morphological data obtained by observing 
Romanowsky stained preparations by light microscopy. There 
are five main cell lineages; lymphoid, erythroid, myeloid, 
megakaryocytic and monocytic.In the normal adult each cell 
lineage consists of a morphologically defined set of cells 
found in the bone marrow.The earliest recogniseable cell in 
any cell lineage pathway is the blast. Given the 
appropriate stimulus the blast divides and differentiates 
to give rise to the mature functioning cell(Figure 1).
Haematopoietic cells are thought to arise from stem
4
cells which have the ability to divide and differentiate 
into cells of any series. Evidence for the existence of 
these pluripotent stem cells was first obtained in mice 
where radiation damaged chromosomes, used as markers, were 
recognised in all cell lineages including the lymphoid 
series (Barnes ^  a3^  .,1952). Additional evidence was
provided by the use of isoenzymes of glucose-6-phosphate 
dehydrogenase as markers.These studies indicated that 
erythocytes, granulocytes and lymphocytes had a common 
ancestor (Gandini and Gartler, 1969; Fialkow, 1979). The 
presence (Lala and Johnson, 1978) and the absence (Paige 
et al , 1979) of chromosomally marked progenitors of 
B-lymphocytes in splenic colonies indicated that separate 
stem cells existed for lymphoid and n^eloid cells. The 
Philadelphia chromosome is present in the cells of the 
erythroid, granulocytic, monocytic, and megakaryocytic 
cells but is absent in the lymphoid cells of chronic 
granulocytic leukaemia. This finding, again, suggests that 
separate stem cells are present for lymphoid and myeloid 
cells (Figure 2).
The study of early cells in haematopoiesis has been 
facilitated by the introduction of clonal culture 
techniques. In 1961 Till and McCulloch reported the assay 
of haematopoietic stem cells by the mouse spleen colony 
technique. In this assay haematopoietic cells introduced 
into a lethally irradiated mouse gave rise to macrosocopic 
colonies on the spleen of the mouse. These colonies may be 
erythroid, granulocytic or megakaryocytic and have been 
shown to be derived from a single cell. This pluripotent
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stem cell is known as a colony-forming unit-spleen (CFU-S).
The culture of granulocyte and macrophage colonies in 
the semi-solid agar technique was described independently 
by two groups of workers (Ichikawa e^ ad , 1966, Bradley 
and Metcalfe, 1966). In this system, stem cells, called 
colony-forming units-culture (CFU-C), give rise to 
microscopic colonies of 50 or more granulocytic and/or 
macrophage cells. A growth factor, called 
colony-stimulating factor (C.S.F.) by Bradley and Metcalf 
(1966) and macrophage granulocyte inducer (M.G.I.) or 
mashran gm by Ichikawa ej^  a^ . (1966) , stimulates the 
growth and differentiation of these colonies. The most 
widely used name for this factor is colony-stimulating 
factor or C.S.F. Colony-stimulating activity or C.S.A. is a 
term generally reserved for impure material which 
stimulates the formation of colonies. C.S.F. is a 
glycoprotien of molecular weight 20,000-80,000 present in 
urine, serum and media conditioned by a number of cell 
types. Two murine C.S.F's, with different biological and 
physico-chemical properties, have been extensivly purified. 
One of these factors termed GM-CSF has been isolated from 
mouse lung-conditioned medium and stimulates the formation 
of granulocyte and/or macrophage colonies in vitro (Burgess 
et al., 1977a). The other factor, isolated from L-cell 
conditioned medium and termed M-CSF, stimulates the 
production of macrophage colonies in vitro (Stanley and 
Heard, 1977).
One of the best characterised C.S.A.’s acting on human 
bone morrow cells is that obtained from human placental 
conditioned medium (Burgess et al, 1977b ; Nicola e_^  ^
., 1978). Human placental conditioned medium (H.P.C.M.) 
contains at least three different colony stimulating 
factors separable by phenyl-sepharose hydrophobic 
interaction chromatography. One of these factors, 
designated EO-CSF, stimulates the formation of eosinophil 
colonies, a second, designated GM-CSFa, stimulates the 
formation of granulocyte and macrophage colonies by day 14 
of culture, and a third, designated GM-CSFy5, stimulates the 
formation of granulocyte and macrophage colonies by day 7 
of culture. GM-CSFyg is completely separated from EO-CSF and 
GM-CSF A: by phenyl-sepharose hydrophobic interaction 
chromatography (Nicola et al., 1979).
Many sources of C.S.F. have been described.Recently, 
Abboud e^ ai_ ., (1981) described colony stimulating 
factors present in giant cell tumour conditioned medium 
(G.C.T.). They reported that this source may contain 
C.S.F.’s similar to those found in human placental 
conditioned medium. The sources of a selection of colony 
stimulating factors are listed in Table 2.
Colony-stimulating factor is assayed by the semi-solid 
agar culture technique (Metcalf, 1977). This bioassay has 
been difficult to standardise since no suitable stable 
standard is currently available. The results of one 
laboratory are often obtained using different assay
7
conditions from those of another laboratory.
In the present study GM-CSF/) from human placental 
conditioned medium has been purified by calcium phosphate 
gel absorption, ultrafiltration, phenyl-sepharose 
chromatography and gel filtration on Sephacryl S-200 
superfine to yield material with a specific activity of 
7240 colonies/mg. In order to investigate the feasability 
of estabilishing a radioimmunoassay for this C.S.F, the 
purified material was radioiodinated and the binding of 
this radioiodinated GM-CSF/3 to an antiserum raised against 
a less pure preparation has been studied. A 
radioimmunoassay could provide a more convenient and more 
specific means of measuring GM-CSl^ levels in biological 
fluids.
Since Abboud et al., 1981 reported that giant cell 
tumour conditioned medium contained C.S.F.’s similar to 
those found in human placental conditioned medium, colony 
stimulating factors were isolated from G.C.T. in the 
present study. C.S.F. was purified from giant cell 
conditioned medium by ultrafiltration, phenyl-sepharose 
chromatography, gel filtration and thiolpropyl-sepharose 
chromatography to give a preparation with a specific 
activity of 4000 colonies/mg. A minor peak which appeared 
to have high specific activity was resolved on gel 
filtration. However the insensitivity of the protein assays 
used in this study made determination of specific activity, 
of the material in this peak, impossible.
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In order to study the binding of C.S.F. to target cell 
membranes, C.S.F. from pokeweed mitogen stimulated spleen 
conditioned medium was labelled with horseradish 
peroxidase. The labelled growth factor was observed to bind 
isolated haematopoietic cell membranes and the binding 
exhibited a linear relationship with the membrane protein 
content.
An imbalance in regulator control can lead to, or 
permit, the establishment of cancer (Furth, 1953) . In 
order to clarify the role of haematopoietic growth factors 
and their cell receptors in leukaemia two lines of 
investigation may be employed. First, plasma levels of 
GM-CSF could be measured using the radioimmunoassay and 
secondly, the binding of radioiodinated GM-CSF to 
leukaemia cells could be studied. These studies could 
estabilish if leukaemia is due to an upset in regulator 
levels or to abnormal receptors for haematopoietic growth 
factors.
Figure 1; A diagram showing cell lineage pathways 
in haematopoiesis.
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Figure 2: The inter-relationship of early progenitor cells
in haematopoiesis.
CFU-S = colony-stimulating unit-spleen.
CFU-GEMM = -granulocyte, erythrocyte, monocyte, myeolcytic. 
CFU-C = colony forming unit-culture.
BFÜ-E = burst forming unit-erythroid.
CFU-E = colony forming unit-erythroid.
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Table 1 : Growth Factors in Haematopoiesis.
Growth Factors in Haematopoiesis
Factor Cell Type Author
Erythropoietin 
Thrombopoietin 
Thymopoietin 
Interleukin - 2 
Interleukin - 3 
GM-CSF
G-CSF
M-CSF
B-cell growth factor
Red Blood Cells
Platelets
T-lymphocytes
T-lymphocytes
Stem cells
Granulocytes 
and monocytes
Granulocytes
Monocytes
B-lymphocytes
Carnot and Deflandre (1906)
Abildaard> and Simmone (1967)
Goldstein (1974)
Gillis and Smith (1977)
Fung et al. (1984)
Pluznik and Sachs (1966) 
Bradley and Metcalf (1966)
Nicola et al. (1983)
Stanley and Heard (1977)
Thoman andiWeigle (1983)
Table 1
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A BIOCHEMICAL STUDY OF POLYPEPTIDE GROWTH FACTORS RESPONSIBLE 
FOR THE GROWTH OF HAEMATOPOIETIC CELLS IN CULTURE
INTRODUCTION
INTRODUCTION
Colony-stimulating factor (CSF) is thought to occur as 
several molecular species which differ in their target cell 
specificities and in their physicochemical properities.
Two distinct murine C.S.F.*s have been extensively 
purified. One of these C.S.F.*s, the C.S.F. from L - cell 
conditioned medium, induces monocyte or macrophage colony 
formation in the murine semi-solid agar culture technique, 
has an apparent molecular weight of 70,000 and is thought 
to consist of two similarly charged polypeptide chains, of 
molecular weight 35,000, held together by disulphide bonds. 
(Stanley and Heard, 1977). The second murine CSF, a CSF
purified from mouse lung - conditioned medium , induces
granulocyte, monocyte, macrophage and mixed 
granulocyte/macrophage colonies in the culture of murine 
bone marrow cells in the semi-solid agar technique. This 
CSF is reported as having an apparent molecular weight of
29,000 (Burgess e^ ^  , 1977a).
Recently, the gene encoding a murine G.M.-C.S.F, from 
lung tissue has been cloned,the D.N.A. sequenced and the 
amino acid sequence deduced (Gough et al.,1984). The 
deduced amino acid sequence is given in Figure 3.
One of the few human C.S.F’s. to be extensively 
purified is that from human urine. This C.S.F. has a 
molecular weight of between 40,000 and 85,000. Human 
urinary C.S.F. induces the formation of murine 
haematopoietic cell colonies in the semi-solid agar culture
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technique (Stanley el^  a]^  1975), Evidence for the
induction of human haematopoietic colonies by human urinary 
C.S.F, is unclear. One group of workers (Motoyoshi et al, 
1978) has reported that human urinary C.S.F, induces colony 
formation in human cultures whereas a second laboratory 
(Das ej^  a]^  ., 1981) has reported only cluster formation 
in the culture of human bone marrow cells. The 
colony-stimulating activity from human urine may act 
indirectly on haematopoietic stem cells, by stimulating the 
release of colony-stimulating factors from bone marrow 
monocytes in the semisolid agar culture (Motoyoshi e^ ^  
., 1982).
Recently Das e^ ad^  (1981) reported the 
radioimmunoassay of a C.S.F. which had been extensively 
purified from human urine. This C.S.F. designated C.S.F.-l 
(Stanley, 1979; Das e_t ^  , 1980) stimulated the 
proliferation of murine macrophage cells In vitro .
However the role of human urinary C.S.F. in vivo and in
the clonal culture of human bone marrow cells remains 
unclear.
A convenient source of human active C.S.F. is human 
placental conditioned medium (H.P.C.M.). (Burgess e^ ^
., 1977b). This conditioned medium contains at least three 
different C.S.F.’s which are separable by hydrophobic 
interaction chromatography. One of these factors, GM-CSF-# 
, stimulates the formation of granulocyte and macrophage 
colonies by day 14 of culture; a second factor, designated
14
GM-CSF/3 stimulates the formation of granulocyte and 
macrophage colonies by day of culture; and a third, 
designated EO-CSF, stimulates the formation of eosinophil 
colonies in vitro • GM-CSF ol and EO-CSF elute in the 
breakthrough volume from phenyl - sepharose columns which 
have been equilibrated with 0.03M Tris-HCl buffer pH 7.4, 
containing IM NaCl and 0.01 % (w/v) sodium azide.Separation 
of GM-CSF«and EO-CSF is not possible using this technique. 
GM-CSl^is eluted from the columns by including 50% (v/v) 
ethylene glycol in the equilibrating buffer (Nicola e_t 
^  1979).
Growth Factors are present in biological fluids in low 
concentrations. These molecules, therefore, require 
sensitive techniques for their quantitation. Competitive 
protein binding assays are highly sensitive and may 
overcome many of the problems inherent in bioassays. The 
first competitive protein binding assay was developed by 
Yalow and Berson in the late 1950's. They noticed that the 
binding of 131-I-labelled insulin to antibodies which 
occured in diabetic patients who had received injections of 
insulin was inhibited by unlabelled insulin. Moreover, 
recognition that the amount of labelled insulin bound to 
the antibodies was a quantitative function of the amount of 
unlabelled insulin added to the reaction mixture when the 
concentration of antibody was held constant, led to the 
introduction of a competitive protein binding assay for 
insulin. (Berson and Yalow, 1958).
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In competitive protein binding assays a fixed amount 
of labelled ligand is incubated in the presence of a known 
amount of binding protein and an unknown amount of 
unlabelled ligand. The unlabelled ligand competes with the 
labelled ligand for sites on the binding protein. The bound
material is then separated from the free material and the
amount of bound labelled ligand measured. The amount of 
labelled ligand bound to the protein is inversely
proportional to the amount of unlabelled ligand added to
the reaction mixture.
The most widely used form of competitive protein 
binding assay is radioimmunoassay. Radioimmunoassay 
utilises a radioactively labelled ligand and antibodies as 
the binding protein. A related technique, the 
immunoradiometric assay, was developed by Miles and Hales 
(1968). In this technique the substance to be measured is 
directly assayed by combination with labelled antibody.
Although antibodies are the most widely used binding 
proteins, any protein which can bind the molecule to be 
assayed may be employed. Steriod transport proteins may be 
used to assay steriod hormones and intrinsic factor may be 
used to assay Vitamin B12 (Wide and Killander, 1971).
Plasma membrane receptors have been used as binding 
proteins in the assay of a number of polypeptide hormones 
and this technique is known as radioreceptor assay 
(Lefkowitz e^ ^  , 1970). Radioreceptor assays recognise 
the biologically active site rather than the immunoreactive
16
site, have high association constants and are more easily 
obtained than antibodies.
Alternatives to radionuclides have been sought in 
recent years. Radiolabelled ligands have a relatively short 
shelf life, require specialised counting facilities and are 
potentially hazardous to both laboratory workers and the 
environment. Many candidates have been proposed as 
alternatives to radionuclides. These include; viruses 
(Haimovitch e^ ^  ., 1970) ; metals, (Cais ei^  al^  ., 
1977) ; chemiluminescense precursors (Pratt et al., 1978) ; 
stable free radicals (Leute e^ al^  ., 1972), and 
fluorochromes, (Soini and Hemmila, 1979). At present the 
most promising labels are enzymes, or enzyme inhibitors, 
cofactors or substrates (Voiler ej^  ^  ., 1978).
The aims of the present study are ; to compare 
colony-stimulating factors present in different conditioned 
media ; to investigate the feasiblity of a radioimmunoassay 
for colony-stimulating factor as an alternative to the 
time-consuming bioassay and to investigate the mechanism of 
action of colony stimulating factor by studying the binding 
of labelled colony-stimulating factor to plasma membranes 
from bone marrow cells.
GM-CS]^ from human placental conditioned medium was 
purified by calcium phosphate gel absorption, 
ultrafiltration, phenyl-sepharose chromatography and gel 
filtration on Sephacryl S-200 superfine to a specific
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activity of 7240 colonies/mg. This material gave a single 
precipitin arc on Immunoelectrophoresis* In order to 
investigate the feasability of estabilishing a 
radioimmunoassay for this C.S.F. the purified material was 
radioiodinated and the binding of this radioiodinated 
GM-CSl^ to an antiserum raised against a less pure 
preparation has been studied. A radioimmunoassay is a more 
convenient and more specific means of measuring GM-CSF 
levels, in biological fluids, than the conventional 
bioassay.
Abboud e^ al . (1981) reported that giant cell 
tumour conditioned medium contains colony stimulating 
factors similar to those found in human placental 
conditioned medium. In order to compare the 
colony-stimulating factors present in giant cell 
conditioned medium with those present in human placental 
conditioned medium , C.S.F. was purified from giant cell 
tumour conditioned medium by ultrafiltration, 
phenyl-sepharose chromatography, gel filtration and 
thiolpropyl-sepharose chromatography to give a preparation 
with a specific activity of at least 4000 colonies/mg. A 
minor peak which appeared to have high specific activity 
was resolved on gel filtration. However the insensitivity 
of the protein assays used in the present study made 
determination of specific activity impossible.
In order to study the binding of C.S.F. to target cell 
membranes, C.S.F. from pokeweed mitogen stimulated spleen
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conditioned medium was labelled with horseradish 
peroxidase. The labelled growth factor was observed to bind 
isolated haematopoietic cell membranes and this binding 
exhibited a linear relationship with the membrane protein 
content.
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Table 2; Some biological sources of colony-stimulating
activity.
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Figure 3; The amino acid sequence of colpny-stimulating 
factor from mouse lung. This sequence was deduced from the 
nucleotide sequence of a cloned gene. (Gough et al., 1984).
Ile - Ile - Val ~ Thr - Arg - Pro - Trj) - Lys - His - Val - 
Glu - Al a - Ile - Lys - Glu - Al a “ Leu Asn - Leu - Leu - 
Asp - Asp - Met - Pro - Val - Thr - Leu - Asn - Glu - Glu -
Val - Glu - Val ~ Val - Sex - Asn Glu - Phe - Ser - Phe -
Lys - Lys - Leu - Thr - Cys - Val - Gin - Thr - Arg - Leu -
Lys - Ile - Phe - Glu - Gin - Gly - Leu - Arg - Gly - Asn -
Phe - Thr - Lys Leu - Lys - Gly - Ala - Leu - Asn - Met -
Thr - Ain - Ser - Tyr - Tyr - Gin - Thr - Tyr - Cys ~ Pro -
Pro - Thr - Pro - Glu - Thr - Asp - Cys - Glu - Thr - Gin -
Val ^ Thr ~ Thr - Tyr *- Ala - Asp - Phe - Ile - Asp - Ser -
Leu - Lys - Thr - Phe - Leu - Thr - Asp - Ile - Pro - Phe -
Glu - Cys - Lys - Lys - Pro - Ser - Gin - Lys
Figure 3
.
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MATERIALS AND METHODS
MATERIALS AND METHODS
All materials used in the present study were of ANALAR 
grade and were obtained from B.D.H. Ltd., Poole, England, 
unless otherwise stated.
PREPARATION OF HUMAN PLACENTAL CONDITIONED MEDIUM
Human placentas were obtained from Caesarean births. 
The placentas were placed in a sterile plastic bag which 
was then knotted, stored at 4®C and used within 12 hr of 
delivery.
The outer membranes were removed from the placentas. 
The placental tissue was cut into Icm^pieces. The pieces 
of placenta were washed (x4) in Hank's balanced salt 
solution. Six pieces of placenta were placed in a flat 
bottomed tissue culture flask containing 20ml R.P.M.I.- 
1640 containing 5% (v/v) foetal calf serum. The flasks 
were incubated at 37°C for 7 days in a fully humidified 
atmosphere of 10% CO2 in air. The conditioned medium was 
filtered through a double layer of cotton gauze and 
centrifuged in a M.S.E. Hi-speed centrifuge 
(M.S.E,,Crawley,England) at 10,000 g for 20 minutes. The 
supernatant was stored at -70*C until used.
CALCIUM PHOSPHATE GEL ABSORPTION OF HUMAN PLACENTAL 
CONDITIONED MEDIUM
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Human placental conditioned medium (101) was dialysed 
against O.OIM sodium phosphate buffer, pH 6.8 (501).Calcium 
phosphate gel (41) was added to the dialysed human 
placental conditioned medium and the mixture stirred. The 
calcium phosphate gel was allowed to sediment and the 
supernatant retained. Sodium phosphate buffer (0.05M), pH 
6.8, was added to the calcium phosphate gel, the mixture 
stirred, allowed to sediment and the supernatant pooled 
with the supernatant from the first elution. The 
supernatant was concentrated 200 fold by ultrafiltration in 
a Amicon DCIO apparatus with an H-10 hollow fibre 
cartridge. The concentrated eluate was stored at -70°C 
until used.
PHENYL-SEPHAROSE HYDROPHOBIC INTERACTION CHROMATOGRAPHY OF 
HUMAN PLACENTAL CONDITIONED MEDIUM
Phenyl-Sepharose CL-4B was packed into a 2.6cm x 13cm
glass chromatography column (L.K.B., Ltd., Bromma, Sweden)
at a flow rate of 18 ml/hr and equilibrated with 500 ml
0.03M Tris-HCl buffer, pH 7.4, containing IM sodium 
chloride.
A sample of human placental conditioned medium in 
0.03M Tris-HCl buffer, pH 7.4, containing IM sodium 
cholride was applied to the column and eluted with the 
equilibrating buffer. The elution was continued at a flow
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rate of 18 ml/hr and the absorbance constantly monitored 
using an ISCO UA-4 absorbance monitor (Instrument 
Specialities Corporation, Lincoln, Nebraska, U.S.A.) at 280 
nm. When the absorbance had decreased to baseline level the 
elution buffer was changed to 50% (v/v) ethylene glycol in 
0.03M Tris-HCl buffer, pH 7.4, containing IM sodium 
chloride.
PROTEIN DETERMINATION
Proteins were determined by a dye binding technique 
(Bradford, 1976). Briefly 1 ml of a solution of 0.1% (w/v) 
Coomassie Brilliant Blue G-250, 4.7% (w/v) ethanol and 8.5% 
(w/v) phosphoric acid was added to a semi -micro cuvette 
containing 0.1 ml of the solution to be assayed. The 
contents of the cuvette were mixed by inversion and the
absorbance read at 595 nm. A calibration curve was
constructed using bovine serum albumin at concentrations of 
10-100 pg/ml.
BIOASSAY FOR COLONY-STIMULATING FACTOR
Colony-stimulating factor was assayed by a 
modification of the method of Stanley al (1972).
The material to be assayed was made 0.1% (w/v) with respect
to bovine serum albumin (Miles Laboratories,Nashville,TN., 
U.S.A) and dialysed against 0.02M potassium phosphate 
buffer, pH 7,3, containing 0.15M sodium chloride. This 
material was Millipore filtered (0.45ju pore size) and
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serially diluted 1:4. An aliquot (0.1ml) of each dilution 
(including the undiluted material) was added, in 
triplicate, to 35mm petri dishes (Nunc,Denmark). 7.5 x 10* 
bone marrow cells from the femours of three-month old 
C57BL/6 mice (Bainton and Kingham, Hull, England) in 1ml 
Iscove’s modification of Dulbecco’s modification of Eagle's 
minimum essential medium (Flow Laboratories, Irvine, 
Scotland) containing 15% (v/v) foetal calf serum (Flow 
Laboratories, Irvine, Scotland) L-asparagine and D.E.A.E. - 
Dextran (Pharmacia, Uppsala, Sweden) were added to each 
petri dish. The petri dishes were placed in a sealed 
container containing 10% CO2 in humidified air and 
incubated at 37*C for 7 days. The number of colonies 
consisting of ^0 or more cells were counted using an 
Olympus dissecting microscope at x 40 magnification. The 
biological activity of each assay was expressed as the mean 
of the triplicate determinations. Figure 4 outlines the 
steps used in the bioassay of colony stimulating activity.
ULTRAFILTRATION AND HYDROPHOBIC-INTERACTION CHROMATOGRAPHY 
OF GIANT CELL TUMOUR (G.C.T.) CONDITIONED MEDIUM
The procedures used to prepare G.C.T.- conditioned 
medium were essentially those of Abboud e^ al^  ., (1981). 
G..C.T. conditioned medium was otained from GIBCO, Paisley, 
Scotland, and concentrated 5-fold by ultrafiltration 
(Amicon) using a PM-10 membrane. The concentrated G.C.T. 
conditioned medium was dialysed against 0.03 M Tris-HCL
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buffer, pH 7.4 containing 0.02% (w/v) sodium azide and 
0.01% (w/v) polyethlene glycol 6000. This solution was 
designated G.C.T. - stage I. An aliquot (15ml) of this 
material was applied to a 2.6cm x 16.0 cm glass 
chromatography column (L.K.B., Bromma, Sweden) of 
phenyl-sepharose 4B (Pharmacia, Uppsala, Sweden) at a flow 
rate of 12ml/hr. Elution was continued using 0.03 M 
Tris-HCL buffer, pH 7.4 containing 0.02% (w/v) sodium azide 
and 0.01% (w/v) polyethylene glycol 6000. Fractions (3ml) 
were collected and the elution monitored by measuring the 
absorbance at 280nm (Pye-Unicam, Cambridge, England) and by 
bioassay. Active fractions were pooled, concentrated 10 
fold using polyethylene glycol 6000, the biological 
activity measured and the active fractions stored at -70*C 
until used. The concentrated material was designated 
G.C.T.-stage II.
Colony-stimulating activity which bound to the 
phenyl-sepharose 4B was eluted with 50% (v/v) ethylene 
glycol in 0.03 M Tris-HCL, pH 7.4 containing 0.02% (w/v) 
sodium azide and 0.01% (w/v) polyethylene glycol 6000. 
Fractions containing colony-stimulating activity were 
pooled and stored at -70*C until used.
GEL PERMEATION CHROMATOGRAPHY OF G.C.T.-STAGE II
A 2.6cm X 66.0cm glass chromatography column was 
packed with Sephacryl S-200 (Superfine grade; Pharmacia 
Ltd., Uppsala, Sweden) and equilibrated with 0.03 M
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Trls-HCL buffer, pH 7.4, containing 0.5 M NaCl, 0.02% (w/v) 
sodium azide and 0.01% (w/v) polyethylene glycol 6000 at a 
flow rate of 18ml/hr. A 0.1% (w/v) solution of Blue Dextran 
2000, molecular weight 2 x 10 , was applied to the column 
to determine the void volume (Vo). Calibration proteins; 
ribonuclease A (molecular weight 25,000), ovalbumin 
(molecular weight 43,000 and bovine serum albummin 
(molecular weight 67,000), were applied to the column at a 
flow rate of 18ml/hr. The absorbance of each fraction was 
measured at 280nm using a U.V.-visible spectrophotometer 
(Pye-Unicam, Cambridge, England) and the elution volume 
(Ve) of each protein recorded. The data were plotted on a 
graph of Kav against log molecular weight where;
V - Vo 
Kav = ----------
Vt - VO
and Ve « elution volume of protein
Vo = void volume of column
Vt = total bed volume of column.
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An aliquot (2ml) of either G.C.T.-stage II or 
G.M.-C.S.F from human placental conditioned medium was 
applied to the column. Fractions (3ml) were collected and 
their absorbance measured at 280nm (Pye-Unicam, Cambridge, 
England). The colony-stimulating activity of each fraction 
was assayed and active fractions pooled and stored at -70°C 
until used. The G.C.T. material fractionated by this 
technique was designated G.C.T.-stage III.
THIOLPROPYL-SEPHAROSE 6B CHROMATOGRAPHY OF G.C.T.-STAGE III
A 0.9cm X 15cm glass chromatography column (Pharmacia, 
Uppsala, Sweden) was packed with thiolpropyl-sepharose 6B 
(Pharmacia, Uppsala, Sweden) and equilibrated with 0.03 M 
Tris-HCl buffer pH 7.4, containing 0.5 M NaCl, 0.02% (w/v) 
sodium azide and 0.01% (w/v) polyethylene glycol 6000. An 
aliquot (4ml) of G.C.T.-stage III was dialysed against 
0.03 M Tris-HCL buffer pH 7.4, containing 0.5 M NaCL, 0.02% 
(w/v) sodium azide and 0.01% (w/v) polyethylene glycol 6000 
and applied to the column. The column was eluted with the 
equilibrating buffer at a flow rate of 8ml/hr and 3ml 
fractions collected. The fractions were monitored by 
measuring the protein content (Bradford, 1976) and by 
assaying for colony-stimulating activity. Those fractions 
containing colony-stimulating activity were pooled and 
designated G.C.T. stage IVA. When the breakthrough peak had 
eluted, the proteins bound to the gel were eluted with the 
equilibrating buffer containing 25mM cysteine. This
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material was designated G.C.T.-stage IVB. An aliquot (2ml) 
of G.C.T. stage IV A was applied to the gel permeation 
chromatrography column to verify the molecular weight of 
the protein.
RAISING OF ANTIBODIES TO COLONY-STIMULATING FACTOR FROM 
HUMAN PLACENTAL CONDITIONED MEDIUM
Colony-stimulating factor (0.7mg H.P.C.M. lib) in 1ml 
phosphate buffered saline (Oxoid Ltd., England) and 1ml of 
Freund’s complete adjuvant (Miles Laboratories Ltd., 
Nashville, TN., U.S.A.) were mixed by ultrasonication 
(M.S.E. Crawley, England) to form an emulsin. The emulsin 
was injected subcutaneously into either a New Zealand white 
rabbit or a Sandyraop rabbit at multiple sites. Four weeks 
later, 0.7mg of colony-stimulating factor in 1ml of 
phosphate buffered saline and 1ml incomplete Freund's 
adjuvant (Miles Laboratories Ltd., Nashville, TN., U.S.A.) 
were mixed by ultrasonication and injected subcutaneously 
into the same rabbit. After a further two weeks a sample of 
blood was collected in a glass centrifuge tube and allowed 
to clot overnight at 4°C. The blood was centrifuged at 500 
X g for 10 minutes and the serum aspirated and stored at 
-70®C until required. Booster injections of 
colony-stimulating factor in incomplete Fruend's adjuvant 
were given at appropriate intervals.
In some experiments the immunoglobulins in the rabbit
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serum were precipitated using 50% (w/v) ammonium sulphate 
(B.D.H. Chemicals Ltd., Poole, England) which had been 
adjusted to pH7.0 using 6M ammonium hydroxide. The 
precipitated proteins were collected by centrifugation at
10,000 X g for 10 minutes in a M.S.E. Hi-speed 18 
centrifuge (M.S.E. Crawley, England) using a 8 x 50ml 
rotor. The proteins were reconstituted in either 10ml of 
0.12M Tris-HCL buffer pH 7.5, containing IM sodium 
chloride, 0.01% (w/v) sodium azide and 0.01% (w/v) 
polyethylene glycol or in phosphate buffered saline 
containing 0.02% (w/v) sodium azide. The proteim 
concentration of each antibody preparation was measured by 
the dye binding technique of Bradford (1976).
The ability of the antiserum to inhibit colony 
formation was investigated by adding serial dilutions of 
the antiserum to the bioassay of C.S.F.
IMMUNODIFFUSION
Two dimensional immunodiffusion was performed by the 
method described by Ouchterlony and Nilsson (1978). Agarose 
(1.5gm HGT grade. Miles Laboratories Ltd., Nashville, TN., 
U.S.A.) was added to 100 ml phosphate buffered saline and 
dissolved by heating in a boiling water bath. The molten 
agarose was poured onto a plastic immunodiffusion plate 
(Miles Laboratories Ltd., Nashville, TN., U.S.A.) and 
allowed to solidify at room temperature. Holes (5mm 
diameter) were punched in the agarose using a template and
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vacuum pump operated gel punch (Miles Laboratories Ltd., 
Nashville, TN., U.S.A.) Appropriate dilutions of the 
various C.S.F. preparations were placed in the central 
wells and appropriate dilutions of antl-CSF placed in the 
outer wells. In some experiments antibody was placed in 
the central well and antigen in the outer wells. The 
immunodiffusion plates were incubated at room temperature 
overnight and examined for precipitin lines. Unprecipitated 
proteins were eluted from the gel by incubating in 2% (w/v) 
NaCl and the ^ precipitin lines stained by the Coomassie Blue 
technique described.
IMMUNOELECTROPHORESIS
Immunoelectrophoresis was performed using the 
technique described by Grabar and Williams (1953).Briefly, 
1.5g agarose (H.G.T. grade. Miles Laboratories Ltd., 
Nashville, TN,, U.S.A.) were added to 100 ml 0.003M 5*,5* 
Diethylbarbituric acid/0.017M sodium 5*,5*
diethylbarbiturate, pH 8.6 containing 0.051% (w/v) calcium 
lactate dissolved by heating in a boiling water bath. 20ml 
of the molten agarose were poured onto a 8.0cm x20.0cm 
glass plate held on a levelling table. The gel was allowed 
to solidify at room temperature and holes punched using a 
Grabar and Williams immuno-template. The holes were filled 
with various C.S.F. preparations and electrophoresis 
performed at 40 mA for 90 minutes in 0.0075M 5,5* 
Diethylbarbituric acid/0.042M sodium 5%5* 
diethylbarbiturate containing 0.083% (w/v) calcium lactate.
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The power was switched off, the gel removed and placed on 
the Grabar and Williams template. A central trough was cut 
using the template and 50pl anti-CSF placed in each trough. 
Precipitin arcs were allowed to develop by Incubating the 
gels overnight at room temperature in a humid chamber. 
Unprecipitated proteins were eluted by incubating the gels 
in 2% (w/v) NaCl for 2 hours and the precipitin lines 
stained by the Coomassie Blue technique described. All 
apparatus was from Shandon Southern Ltd., Runcorn, England.
COOMASSIE BLUE R-250 STAINING
Proteins in immunodiffusion and immunoelectrophoresis 
gels were stained using Coomassie Blue R-250. The gels to 
be stained were incubated for 2-24 hours at room 
temperature in a staining solution comprising 0.2% (w/v) 
Coomassie Blue R-250 (Sigma Chemical Co., St. Louis, MO., 
U.S.A.) in 95% (v/v) ethanol to which an equal volume of 
20% (w/v) glacial acetic acid had been added immediately 
before use. The gels were destained in a solution of 400 ml 
ethanol and 600 ml 5% (v/v) acetic acid overnight.
RADIOIODINATION OF COLONY-STIMULATING FACTOR
GM-CS^# was radioiodinated by a modification of the 
chloramine-T method of Greenwood el^  a]^  (1963). A 10/tCi
aliquot of Na-125—I solution (Amersham International 
P.L.C., Amersham, England) was dispensed into a polystyrene
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tube (B.C.L., Lewes, England). lOfil of 0.25M sodium 
phosphate buffer, pH 7.5 containing 1.875M dimethyl 
sulphoxide and 0.01% (w/v) polyethylene glycol 6000 were 
added and the following added in rapid succession whilst 
the reaction mixture was continuously stirred; lO/il (0.1 
mg/ml) of GM-CSF ; lOjuil (50ug) of chloramine-T in 0.05M 
sodium phosphate buffer, pH 7.5; lOQjil (120ug) of sodium 
metabisulphite in 0.05 M sodium phosphate buffer, pH 7.5. 
All solutions contained 1.875M dimethyl sulphoxide and 
0.01% (w/v) polyethylene glycol 6000. The volume of the 
solution was adjusted to 1.0ml using 0.2% (w/v) sodium 
iodide in 0.05 M sodium phosphate buffer, pH 7.5, 
containing 2% (v/v) horse serum (Flow Laboratories, Irvine, 
Scotland).
Sephadex G-25 (medium grade, Pharmacia, Uppsala, 
Sweden) in 0.25 M sodium phosphate buffer, pH 7.5 
containing 2% (v/v) horse serum and 0.01% (w/v) sodium 
azide was packed in a 0.9 cm x 12 cm chromatography column 
(Pharmacia, Uppsala, Sweden) and equilibrated with the same 
buffer. The iodination mixture was applied to the column at 
a flow rate of 18ml/hr and eluted with 0.25M sodium 
phosphate buffer, pH 7.5, containing 2% (v/v) horse serum 
and 0.01% (w/v) sodium azide. Fractions (2ml) were 
collected in polystyrene tubes and the radioactivity of 
each fraction counted using a Wilj 2101 gammacounter. (Wilj 
International Ltd., Ashford, England).
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BINDING OF RADIOIODINATED GM-CSF TO ANTI-C.S.F.
Aliquots (0.1ml) of serial dilutions (10, 10^, 10^, 10^ 
, 10^) of anti-CSF and GM-CSF/9 were added to each of a 
series of test tubes. The mixtures were incubated for one 
hour at 37*^ 0 and 0.1ml of 125-I-GM-CSF/5 were added to the 
incubaton mixtures which were further incubated at 37°C for 
two hours. The incubation mixtures were then transferred to 
4^C and incubated for 18-144 hr. On completion of this 
imcubation 0.1ml of 0.1% (w/v) E.D.T.A., disodium salt and 
0.1ml of an appropriate dilution of goat anti-rabbit IgG 
(Miles Laboratories, Nashville, TN. U.S.A.) were added 
according to the instructions supplied by the manufacturer 
of the second antibody. The samples were mixed and 
incubated at 4^  C for 18 hr. An aliquot (1.0ml) of 0.1 M 
Tris-HCl buffer, pH 7.5 containing 1 M sodium chloride,
0 .01% (w/v) sodium azide and 0.01% (w/v) polyethylene 
glycol 6000 was added and the mixtures were centrifuged at 
500 X g for 15 minutes. The supernatant was carefully 
aspirated and each precipitate was counted using a Wilj 
2101 gammacounter (Wilj International Ltd., Ashford, 
England).
PREPARATION OF PROTEIN-ENZYME CONJUGATES
Glucagon and C.S.F. were labelled with horseradish 
peroxidase (donor: hydrogen-peroxide oxidoreductase; E.G. 
1.11.1.7, type X, Sigma Chemical Co., St. Louis, MO.,
U.S.A.) Briefly, Img of the protein to be labelled and 5mg
34
enzyme were dissolved in 2ml 0.04M sodium phosphate buffer 
pH 7.4, containing 2.5% (v/v) glutaraldehyde and shaken at 
room temperature for 3 hours. This mixture was applied to a 
1.6 cm X 40 cm glass chromatography colum (Pharmacia, 
Uppsala, Sweden) of Sephadex G-150 (Pharmacia, Uppsala, 
Sweden) equilibrated with 0.04 M sodium phosphate buffer, 
pH 7.4 containing 0.5M NaCl. The proteins were eluted using 
the same buffer and 2ml fractions collected using a 
FRAC-100 fraction collector (Pharmacia, Uppsala, Sweden). 
The flow rate was maintained at 6ml/hr using a P-1 
peristaltic pump (Pharmacia, Uppsala, Sweden). The elution 
of the proteins was followed by measuring the optical 
density of each fraction at 280nm on a SP-6 
spectrophotometer (Pye Unicam, Cambridge, England).
MEASURMENT OF PEROXIDASE ACTIVITY
The substrate solution was prepared by dissolving 40 
mg 5 - aminosalicylic acid in 100 ml 0.02M sodium phosphate 
buffer, pH6.0 containing 5jul H2O2 .Substrate solution (1 ml) 
was added to each sample to be assayed.The absorbance at 
450nm was read, after 1 hour at room temperature, using a 
SP-6 spectrophotometer (Pye-Unicam, Cambridge, England).
BINDING OF ENZYME - LABELLED GLUCAGON TO MEMBRANE RECEPTORS
In an experiment to ascertain the feasability of using 
enzyme - labelled proteins to study membrane receptors,
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glucagon was labelled with horseradish peroxidase and the 
binding of this conjugate to rat liver plasma membranes 
investigated.
Plasma membranes were prepared by the method of Lesko 
et al (1973). A polymer solution was prepared by mixing 
200g 20% (w/v) aqueous Dextran T500 (Pharmacia, Uppsala, 
Sweden), 30% (w/v) aqueous polyethylene glycol 6000, 333ml 
0.22 M sodium phosphate buffer pH 6.5 and 179ml glass 
distilled water in a separating funnel and incubated at 4® C 
for 96 hours. The two liquid phases were collected and 
stored at 4*0.
The liver from a rat was removed and washed in 0.001 M 
sodium bicarbonate buffer pH 7.5, containing 0.0005 M CaCl 
. The liver was them chopped finely and homogenised in 
0.001 M sodium bicarbonate buffer pH 7.5, containing 0.0005 
M CaCl to lOOx the wet weight of the liver, allowed to 
stand for 5 minutes at 4**C and the fibrous tissue removed 
by filtration through surgical gauze.
The filtrate was centrifuged at 1000 x g for 30 
minutes in a M.S.E. Hi-speed 18 centrifuge (M.S.E.,
Crawley, England) using a 8 x 50ml rotor and the 
supernatant discarded. The membrane rich pellet was 
resuspended in 0.001 M sodium bicarbonate buffer containing 
0.0005 M CaCl2 by gentle homogenisation (4-6 strokes) in a 
Potter homogeniser and diluted to half the original volume 
with the same buffer. The homogenate was then centrifuged 
at 1100 X g for 15 minutes in a M.S.E. Hi-speed 18 
centrifuge (M.S.E., Crawley, England) using a 8 x 50 ml
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rotor.
The supernatant was discarded and the pellet was 
suspended in 30ml upper phase polymer by gentle 
homogenisation.An aliquot (10ml) of lower phase polymer was 
added to 10ml aliquots of the homogenate in upper phase 
polymer, mixed and centrifuged at 1100 x g for 15 minutes. 
Plasma membranes were removed from the polymer interface 
and resuspended in 30ml upper phase polymer.An aliquot 
(10ml) of lower phase polymer was added to 10ml aliquots of 
the plasma membranes in upper phase polymer, mixed and 
centrifuged at 1100 x g for 15 minutes, the plasma 
membranes were removed from the polymer interface and added 
to 30ml of upper phase buffer.An aliquot (10ml) of lower 
phase buffer was added to 10ml aliquots of the plasma 
membrane preparation, mixed and centrifuged at 1100 x g for 
15 minutes. The plasma membranes were removed from the 
polymer interface, suspended in 30ml 0.05 M Tris-HCl buffer 
pH 7.5 and centrifuged at 2400g for 10 minutes in a MSE 
Hi-speed 18 centrifuge using a 8 x 50ml rotor. The 
supernatant was discarded and the membrane preparation 
washed three times in 0.05 M Tris-HCl buffer pH 7.5. The 
final membrane pellet was resuspended in 10ml 0.05 M 
Tris-HCl buffer, pH 7.5 and stored in 500ul aliquots at -20* 
C.
Horseradish peroxidase was coupled to glucagon (Sigma 
Chemical Co., St. Louis, MO., U.S.A.) as described 
previously.
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In the binding experiment tptal binding was measured 
by mixing 500|il membrane suspension, AOOul 2% (w/v) bovine 
serum albumin (Miles Scientific Ltd., Nashville, TN., 
U.S.A.) in 0.05M Tris-HCl buffer, pH 7.5 and lOOpl 
horseradish peroxidase-glucagon conjugate. The mixture was 
incubated at 25*C for 30 minutes, centrifuged at 2400 x g 
for 10 minutes at 4*C in a M.S.E. Hi-speed 18 centrifuged 
using a 8 X 50ml rotor (M.S.E., Crawley, England). The 
pellet was then washed three times in 0.05 M Tris-HCl 
buffer pH 7.5 and the enzyme activity of the pellets 
measured. Non-specific binding was measured by mixing 500/il 
membrane suspension, 300jil 2%(v/v) bovine serum albumin in 
0.05 M Tris-HCl, pH 7.5, lOOpl horseradish 
peroxidase-glucagon conjugate and lOOpl luM glucagon in a 
test tube, incubating at 25*C for 30 minutes, centrifuging 
at 2400 X g for lOminutes at 4®C and washing the pellet 
three times in ice-cold 0.05M Tris-HCl pH 7.5. The 
peroxidase activity of the final pellet was measured as 
described previously.
The total peroxidase activity of the horseradish 
peroxidase-glucagon conjugate added to the reaction 
mixtures was measured as previously described. Total 
binding and non-specific binding assays were performed in 
triplicate.Specific binding was calculated by subtracting 
the non-specific binding from the total binding and 
expressing as a percentage of the peroxidase activity added 
to the reaction mixture.
BINDING OF ENZYME LABELLED COLONY-STIMULATING FACTOR TO
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HAEMATOPIETIC CELL MEMBRANE RECEPTORS
Bone marrow cells were extracted from the feraours of 
20 C57BL/6 mice (Baintin and Kingham, Hull, England) and 
collected in 0.001 M sodium bicarbonate buffer pH 7.5, 
containing 0.0005 M CaCl . The bone marrow cells were 
homogenised using 20-30 strokes of a Potter homogeniser and 
plasma membranes prepared by the same method used to 
prepare the rat liver membranes.
Colony-stimulating factor was prepared from pokeweed 
mitogen stimulated spleen cell conditioned medium as 
described by Burgess elt al^  (1980). This C.S.F. 
preparation was labelled with horseradish peroxidase and 
the binding of the enzyme labelled growth factor to bone 
marrow cell membranes was studied using an identical 
protocol to that used to study the binding of enzyme - 
labelled glucagon to plasma membrane receptors.
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Figure 4 : A diagram illustrating the bioassay of colony-
stimulating activity.
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RESULTS
RESULTS
PREPARATION OF HUMAN PLACENTAL CONDITIONED MEDIUM
The human placental conditioned medium contained 
maximal colony-stimulating activity by day 4 to day 7 of 
culture. The conditioned medium was harvested at day 7 and 
pooled with other human placental conditioned media 
containing active material. The pooled material, designated 
H.P.C.M.-I, was stored at -70*C until further processed.
CALCIUM PHOSPHATE GEL ABSORPTION
The H.P.C.M.-I was dialysed against four changes of 
0.01 M sodium phosphate buffer pH 6.8. Calcium phosphate 
gel was then added to the H.P.C.M.-I in the 0.0IM sodium 
phosphate buffer pH 6.8. Colony-stimulating activity 
remained in the supernatant whilst most of the protein 
bound to the gel. The supernatant (designated H.P.C.M.-II) 
was removed and concentrated by ultrafiltration (Amicon) 
using a PM-10 membrane. The concentrated material was 
designated H.P.C.M.-IIb and stored in 15ml aliquots at -70° 
C until required for future experiments. For practical 
reasons this was regarded as the starting material for 
further purification procedures.
PHENYL-SEPHAROSE HYDROPHOBIC INTERACTION CHROMATOGRAPHY OF 
H.P.C.M.-IIb
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Figure 5 shows a typical elution profile obtained when 
H.P.C.M.-IIb was applied to a phenyl-sepharose 6B column. 
Two peaks of colony-stimulating activity were identified on 
hydrophobic interaction chromatography of H.P.C.M.-IIb. The 
breakthrough peak was pooled and the biological activity of 
the pooled material determined. The bound material was 
eluted with 50% (w/v) ethylene glycol and the protein was 
monitored by absorbance at 280nm. Fractions were pooled and 
the biological activity measured. The colony-stimulating 
activity which eluted in the breakthrough peak was shown to 
contain eosinophil and granulocyte-macrophage 
colony-stimulating factors and designated G.M.-C.S.F by 
Nicola e^ al^  ., (1979). The material eluted by ethylene 
glycol from the phenyl-sepharose column was shown to 
contain mainly granulocyte and/or macrophage 
colony-stimulating factors and designated G.M.-C.S.F./? by 
Nicola e^ al^  ., (1979). Active fractions were pooled as 
indicated in Figure 5 and stored at -70*C until used. This 
purification was preformed 8 times during the present study 
and all experiments gave similar elution profiles to that 
shown in Figure 5.
PROTEIN DETERMINATION
Figure 6 shows a typical calibration curve obtained 
using bovine serum albumin as standards in the dye-binding 
technique for protein determination (Bradford, 1976) Each 
point represents the mean of duplicate determinations.
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BIOASSAY OF COLONY-STIMULATING ACTIVITY
The bioassays were performed as described in the 
Materials and Methods section. Each assay was performed in 
triplicate and each of the biological activities reported 
in the present study is the mean of these three 
observations. The number of colonies consisting of greater 
than /40 cells were counted and activity expressed as the 
number of colonies formed per ml of material. Specific 
activity was expressed as the number of colonies formed per 
mg protein in the C.S.F, preparation,
ULTRAFILTRATION AND PHENYL-SEPHAROSE CHROMATOGRAPHY OF 
G.C.T.-CONDITIONED MEDIUM
Chromatography of G.C.T.-conditioned medium was 
performed by the technique described by Abboud ej^  a^ ., 
(1981). The fractions consisting the breakthrough peak were 
pooled and the colony-stimulating activity of this material 
found to be 582 colonies per mg protein.
GEL PERMEATION CHROMATOGRAPHY OF H.P.C.M.-IIB AND G.C.T.- 
STAGE II
Figure 7 shows a typical calibration curve (experiment 
preformed 8 times) for determination of molecular weight 
using gel permeation chromatography on Sephacryl S-200 
superfine gels. A linear relationship was estabilished
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between the Kav and the log molecular weight of the 
calibration proteins. The molecular weights of proteins 
could be determined from this graph.
Gel filtration chromatography of H.P.C.M.-IIb gave a 
single peak of colony-stimulating activity (Figure 8). This 
chromatgraphy was performed 6 times and similar elution 
profiles obtained in each experiment. The molecular weight 
of the active material was confirmed as 30,000.
Gel filtration chromatography of G.C.T. stage-II gave 
two peaks of biological activity (Figure 9). The major peak 
was found to have a specific activity of 4000 colonies/mg 
and a molecular weight of 63,000 whereas the minor peak has 
a biological activity of 280 colonies/ml and appeared to 
have a molecular weight of 30,200. The experiment was 
repeated 4 times with similar results.
THIOLPROPYL - SEPHAROSE 6B AFFINITY CHROMATOGRAPHY OF 
G.C.T.-STAGE III
The majority of the colony stimulating activity from 
G.C.T.-stage III eluted in the breakthrough peak (Figure 
10). The specific activity of this material was found to be 
2,700 colonies/mg. A minor peak of biological activity 
bound to the column and was eluted with the equilibrating 
buffer containing 25mM cysteine. This minor peak had a 
specific activity of 846 colonies/mg Figure 10 shows a 
typical elution profile obtained for 2 separate experiments
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which gave similar results.
Tables summarising the purification scheme for both 
H,P,C.M, (Table 3) and G.C.T, (Table 4) are given,
RAISING OF ANTIBODIES TO C,S.F.
The harvested antisera were examined by a number of 
immunochemical techniques which are described in the 
following sections. The antiserum inhibited the formation 
of colonies in the semi-solid agar culture technique.
The marked precipitin lines, however, may be due to an 
antibody other than an anti-C.S.F.
IMMUNODIFFUSION
Figure 11 shows the precipitin line pattern obtained 
when anti-C.S.F., raised in rabbits against H.P.C.M. lib 
was placed in the central wells of an Ouchterlony-type 
immunodiffusion plate and various C.S.F. preparations from 
human placental conditioned medium and giant cell tumour 
conditioned medium were placed in the outside wells. It can 
be seen that precipitin lines were obtained when the 
anti-C.S.F. was reacted with human placental conditioned 
medium Ilb, giant cell tumour conditioned medium,
G.M.-C.S.F. OL from human placental conditioned medium and 
G.M.-C.S.F./? from human placental conditioned medium. Lines 
of identity were demonstrated between; (i) human placental 
conditioned medium lib and giant cell tumour conditioned
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medium, (ii) human placental conditioned medium and 
G.M,-C.S.F.a, and (iii) between human placental conditioned 
medium lib and G.M.-C*S.F./? ,
IMMUNOELECTROPHORESIS
Figure 12 shows the results of the 
immunoelectrophoresis.Multiple precipitin arcs were visible 
when the H.P.C.M. Ilb was reacted with the antiserum. A 
single precipitin arc was demonstrated when G.M.-C.S.F. 
was reacted with the antiserum and a single precipitin line 
appeared to be present when the antiserum was reacted with
G.M.-C.S.F./?.
COOMASSIE BLUE R-250 STAINING
Precipitin lines and protein stained with Coomassie 
Blue-R-250. The precipitin lines were easier to visulise 
than unstained preparations.
RADIOIODINATION OF C.S.F.
Colony-stimulating factor was radioiodinated by a 
modification of the chloramine-T method. The radioiodinated 
protein was separated from unreacted 125-1 by Sephadex 
G-25 gel permeation chromatography (Figure 13). The 
addition of polyethylene glycol 6000 and dimethyIsulphoxide 
to the reaction mixture prevented loss of biological 
activity during the iodination procedure.
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BINDING OF C.S.F. TO ANTI-C.S.F.
Figure 14 shows a typical binding curve obtained when 
a fixed amount of 125-I-C.S.F. was reacted with anti-C.S.F. 
diluted 1:10,000 in reaction buffer and a known amount of 
C.S.F. preparation.
PREPARATION OF PROTEIN-ENZYME CONJUGATES
Glucagon was coupled to horseradish peroxidase as 
described in the materials and methods section of this 
report. The results of the separation of the products of 
the crosslinking reaction by gel permeation chromatography 
are illustrated in Figure 15. Fractions 62-66 were pooled 
and used in susequent binding experiments.
The chromatography, on Sephadex G-150, of the products 
of the crosslinking reaction between C.S.F. and horseradish 
peroxidase is illustrated in Figure 16. Fractions 23-46 
were pooled and used in subsequent experiments.
ASSAY OF PEROXIDASE ACTIVITY
The results of the enzyme assays are incorporated into 
the results of the binding experiments.
BINDING OF ENZYME LABELLED GLUCAGON TO MEMBRANE RECEPTORS
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The specific binding of horseradish peroxidase 
labelled glucagon to rat hepatocyte membranes (Figure 17) 
exhibited a linear relationship to the membrane protein 
concentration. A rat hepatocyte membrane protein 
concentration of 70pg/ml was sufficient to bind 48% of the 
enzyme-labelled glucagon using a 1:1 dilution of enzyme - 
labelled glucagon.
BINDING OF ENZYME LABELLED C.S.F.TO BONE MARROW MEMBRANE 
RECEPTORS
The specific binding of horseradish peroxidase 
labelled colony-stimulating factor to murine bone marrow 
cell membranes exhibited a linear relationship to the 
membrane protein concentration (Figure 18). A membrane 
protein concentration of 54 /ig/ml was sufficient to bind 
50% of the peroxidase labelled C.S.F. when the dilution of 
conjugate was 1:1.
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Figure 5 : Phenyl-sepharose 4B chromatography of
H.P.C.M. Ilb. The figure shows results from a 
typical experiment. Protein (*^^) was monitored at 
280 nm and biological activity measured as described 
in the text. In the experiment described in the 
figure, the shaded areas ) were pooled and used 
in subsequent purification procedures. The fractions 
from the breakthrough material had a biological 
activity of 400 +30 colonies/ml. The material from
the peak eluted by ethylene glycol was split into 
two pools. Pool \ had a biological activity of 
302+17 colonies/ml and Pool 2 had an activity of 
197+15 colonies/ml* The experiment was performed 8 
times. In all experiments the biological activity 
and protein eluted at similar volumes to those 
indicated in this Figure.
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Figure 6 ; Calibration curve for the determination
of protein using the dye - binding method of 
Bradford (1976). Bovine serum albumin used as 
standards. The figure shows a typical experiment and 
each point on the graph is the mean of two 
observations. Protein determinations were preformed 
a number (>50) of times during the course of this 
study and a calibration curve was constructed on 
each occassion.
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Figure 7 : Typical calibration curve for the
determination of molecular weights of proteins using gel 
permeation chromatography on Sephacryl S-200 superfine 
columns. This experiment was performed 8 times.
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Figure 8 : Gel permeation chromatography of H.P.C.M. lib. 
This diagram shows a typical elution profile obtained 
when H.P.C.M. Ilb was chromatographed on Sephacryl S-200 
superfine. The biological activity eluted with an 
apparent molecular weight of 30,000 (± 78). The
experiment was performed 6 times and similar elution 
profiles obtained in all experiments.
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Figure 9 : Gel permeation chromatography of G.C.T. stage
II. The elution was followed by monitoring protein at 280 
nm ) and by measuring the biological activity
of each fraction. Bars indicate standard errors. The 
experiment was performed 4 times and each C.S.F. assay 
was expressed as the mean of triplicate observations.
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Figure 10 : Thiopropyl-sepharose 6B chromatography of
G.C.T. stage III. The protein content —  ) was
measured by the dye binding technique of Bradford (1976). 
The biological activity ( |  ) was measured as described
in the text and each point on the graph is the mean of 
three observations. Bars indicate standard errors. This 
experiment was performed 4 times and similar elution 
profiles obtained in each experiment.
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Table 3: Summary of the purification of colony-stimulating
factors from human placental conditioned medium.
Step Proteinmg/ml Colonies/ml Specific Activity /mg Yield%
HPCM lib 4.7 650 138 100
Phenyl GM-CSPa Sepharose 0.7 400 571 233
Phenyl Sepharose 1 0.31 300 967 20GM-CSF/5 2 0.28 200 7X4 .35
gel filtration 0.1 724 7240 73
Table 3
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Table 4: Summary of the purification of colony-stimulating
factors from G.C.T. conditioned medium.
VPurification
Stage
Protein
mg/ml
Colonies
/ml
Specific Activity /mg
Yield
%
Crude GCT 1.30 1110 854 100
UltrafiltrateGCT-Stage-I 1.60 1530 956 137
Phenyl-SepharoseGCT-Stage-II 0.91 530 582 48
Gel Filtration 
GCT-Stage-III major peak 0.15 600 4000 54
minor peak 0.005 250 not known not known
Affinity Chrom.
(1) GCT Stage XVA 0.20 540 2700 49
(2) GCT Stage IVB 0.13 110 846 10
Table 4
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Figure 11 : Immunodiffusion in 1.5% (w/v) agarose gels.
Antiserum was placed in the central wells and various 
C.S.F. preparations placed in the outside wells according 
to the key given. The plate shown here was stained with 
Coomassie Blue as described in the text.
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Figure 12 Immunoelectrophoresis in 1.5% (w/v) agarose 
gels. Antiserum was placed in the central trough and 
various C.S.F. preparations placed in the small wells 
according to the key given. The plate shown here was 
stained with Coomassie Blue as described in the text.
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Figure 13 : The separation of 125-1 labelled
colony-stimulating factor from unreacted Na 125-1 on a 
Sephadex G-25, medium grade, column. Fractioi^^rom the 
early peak were pooled, assayed for biological activity 
and used for subsequent binding experiments.The figure 
shows results from a typical experiment. Radioiodination 
of C.S.F. was performed on 22 occassions during the 
present study.
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Figure 14 : Typical binding curve obtained when O.lml
C.S.F. were added to 0.1ml antiserum (diluted 1:10,000 in 
phosphate buffered saline) and the mixture incubated for 
1 hr at 37* C. An aliquot (0.1ml) of I25-I-C.S.F. was 
added to the incubation mixture and incubated for a 
further 2 hr at 37^0. Goat anti rabbit IgG (0.1ml) was 
used to precipitate the 125-I-C.S.F. bound to the 
antiserum. After centrifugation the bound material was 
counted using a gamma counter. Bars indicate standard 
errors.
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Figure 15 : Chromatography on Sephadex G-150 of the
products of the crosslinking reaction used to couple 
horseradish peroxidase to glucagon. The material 
indicated was pooled and used in the binding 
experiments. This experiment was performed on 3 
occassions and the figure shows a typical elution 
profile.
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Figure 16 : Sephadex G-150 gel filtration
chromatography of the products of the crosslinking 
reaction used to link horseradish peroxidase to 
C.S.F. from pokeweed mitogen-stimulated spleen 
conditioned medium. The fractions indicated were 
pooled and used in further experiments. This 
experiment was performed on 6 occassions and the 
figure shows a typical elution profile.
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Figure 17 : The binding of horseradish
peroxldase-glucagon conjugates to a rat liver membrane 
preparation (a) at a conjugate dilution of 1:1, (b) at a 
conjugate dilution of 1:10 and (c) at a conjugate 
dilution of 1:20* The membrane protein concentrations are 
plotted against the specific binding of the labelled 
glucagon to the membrane preparation* Specific binding 
was expressed as the percentage of the peroxidase 
activity present In each assay* Bars indicate standard 
errors* Each point Is the mean of 3 observations.
Specific binding = Total binding - Non-specific binding
50
40
a•H
■spqO
• H
•HO0)PL:co
30
20 *
10.
10 20
— r-
30
—r-
40
— r-50 — r-60 —170
membrane protein .(jig)
Figure 17(a)
-63 _
50
bO
CO
10
10 20 30 40 50 60 70
membrane protein.in (jig)
Figure 17(b)
_ 64 _
•H
•HM
O•HM-t•H
ACO
50
40
30
20
10
10 20 30 40 50 60 70
membrane protein (pg)
Figurg 17 (c)
Figure 18 : The binding of horseradish peroxidase -
C.S.F. conjugates to a membrane preparation from bone 
marrow cells, (a) at a conjugate dilution of 1:1, (b) at 
a conjugate dilution of 1:10, (c) at a conjugate dilution 
of 1:20, and (d) at a conjugate dilution of 1:40. The 
membrane protein concentrations were plotted against 
specific binding of the labelled-C.S.F. to the membranes. 
Bars indicate standard errors. Specific binding was 
expressed as a percentage of the total peroxidase 
activity present in each assay. Each point on the graphs 
is the mean of 3 observations.
Specific binding = Total binding - Non-specific binding
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DISCUSSION
DISCUSSION
In order to investigate the mechanism of action of a 
protein, to determine it's amino acid sequence, or to 
establish an immunoassay for the protein sufficient 
quantities of pure material must be available.
Colony-stimulating factors are polypetide growth 
factors present in low concentrations in urine, serum, and 
cell culture media conditioned by a number of cell types.
A comparison of the relative specific activities of 
different sources of colony-stimulating factor is difficult 
because of lack of standardisation of the bioassay.
The choice of starting material is important in any 
protein purification scheme but is even more important in 
the purification of colony-stimulating factors since they 
are present in such low concentrations in biological 
fluids. Urine contains about 0.6ng CSF-1 per ml, serum 
about 4ng CSF-1 per ml and serum-free L-cell conditioned 
medium about 23ng CSF-1 per ml (Stanley and Guilbert, 
1981). The richest known sources of colony - stimulating 
factors are conditioned media. In particular, the G.C.T. 
cell conditioned medium (Abboud e^ al^  , 1981) and Mo 
cell conditioned media (Golde ^  ^  .,1978) are rich
sources of human colony-stimulating factors. However large 
volumes of starting material are always necessary when 
attempting to purify colony-stimulating factor.
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The techniques which may be employed to concentrate 
these large volumes include pressure dialysis, 
ultrafiltration and lyophilisation. Ethanol or ammonium 
sulphate precipitation is impractical during the early 
stages of purification of colony-stimulating factor 
(Stanley and Metcalf, 1969; Stanley e^ a^ . 1971; 
Burgess al^  • 1977b). The batchwise concentration of
starting material by treatment with DEAE - cellulose or
calcium phosphate gel may also purify the 
colony-stimulating factors (Burgess ej^  ^  . 1976).
Vacuum rotary evaporation at 40 C may also be 
employed to concentrate colony-stimulating factors. In
this technique some proteins are denatured at 40®C 
resulting in some purification of colony-stimlulating 
factors (Stanley and Heard, 1977). In these early 
purification steps it is important to remove any material 
which might be inhibitory to the bioassay. This inhibitory 
material may consist of small toxic molecules which are 
removed by dialysis or larger molecules which are removed 
by dénaturation or by the chromatographic media. There has 
been much speculation on the role of this inhibitory 
material and of the role of inhibitors of granulopoiesis 
in vivo . For example, Broxmeyer ^  al^  . (1982) have 
proposed isoferritins as "feedback regulators" of 
granulopoiesis and monocytopoiesis. It may be that these 
acidic isoferritins may simply remove an essential 
molecule,(perhaps iron) from the medium in which the cells 
are grown (Jacobs, 1984).
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Chromatographic procedures used in the later stages of 
colony-stimulating factor purification include; 
ion-exchange chromatography on DEAE - cellulose, calcium 
phosphate gel chromatography, gel filtration and 
hydrophobic interaction chromatography. Group specific 
bioaffinity chromatography on lectin-sepharose columns may 
be employed for some glycosylated colony-stimulating 
factors (Stanley ej^  a3^  , 1975) and although other types 
of colony-stimulating factor do not bind lectin columns 
this chromatographic step may remove any contaminating 
glycoproteins from the starting material. The use of 
analytical high performance liquid chromatography 
(H.P.L.C.) columns would be useful in the purification of 
small amounts of material especially in the latter stages 
of purification since the amount of protein is small. A 
major problem of working with small amounts of protein is 
the loss of biological activity due to dénaturation or the 
absorption on to the surfaces of vessels and tubing used in 
the experiments.
In the present study the inclusion of polyethylene 
glycol 6000 in all buffers prevented the loss of biological 
activity in dilute solutions (Stanley . 1975;
Stanley and Heard, 1977 and Burgess ej^  ^  . 1977a). In 
addition, all glassware was washed in detergent, rinsed in 
large volumes of double glass distilled water, heated at 
180*C for 2 hours, allowed to cool and, finally, rinsed in 
0.1%((w/v) bovine serum albumin (Sigma Chemical Co., St.
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Louis, MO.,U.S.A.) before being allowed to dry at room 
temperature. All chromatographic tubing etc. was treated 
with 0.1% (w/v) bovine serum albumin before use.
A pure preparation of any colony-stimulating factor 
will help to define the specificities of the polypeptide 
growth factors acting during haematopoiesis. Different 
colony-stimulating factors act on different target cells. 
Some, for example Interleukin - 3, act on early stem cells 
such as the pluripotent stem cells and are mainly 
responsible for the self renewal of these cells although 
interleukin - 3 may induce some differentiation (Fung e^ 
al . 1984). Others, like the granulocyte-macrophage 
colony-stimulating factors act on cells which are 
programmed to differentiate along either the granulocyte or 
macrophage pathways (Burgess e]t ^  . 1977a) whilst 
others, for exammple macrophage colony-stimulating factor 
(M-CSF or CSF-1) (Stanley and Heard, 1977) and granulocyte 
colony-stimulating factor (Nicola ^  al^  . 1983 ; Nicola 
et al . 1985) act on cells programmed to differentiate 
along a single pathway. These growth factors have a 
somewhat more limited action and their main responisibility 
may be as inducers of cellular differentiation (Sachs and 
Lotem, 1984).See Figures 1 and 2.
Conditioned media may contain different haematopoietic 
growth factors showing different target cell specificities 
(Burgess ej^  al^  • 1980) and physico-chemical 
properties.The G.C.T. conditioned medium used in the
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present study gave two peaks of activity on gel filtration. 
The apparent molecular weights of these were 63,000 and 
30,200 respectivly. These may represent two distinct 
molecular species or, the larger molecular weight moiety 
may represent a dimer of the smaller molecule. The active 
material from human placental conditioned medium, on the 
other hand, gave a single peak of biological activity on 
gel filtration. The apparent molecular weight of this 
material was 30,000. In addition to containing colony - 
stimulating factors that appeared in the breakthrough 
volume of hydrophobic gels, both G.C.T. conditioned medium 
and human placental conditioned medium contained colony - 
stimulating factors which bound to these gels.
The purification procedures used in the present study 
yielded GM-CSF from human placental conditioned medium with 
a specific activity of 7240 colonies / mg and this 
exhibited a single precipitin arc against an antiserum 
raised against a crude CSF preparation. The specific 
activity of the C.S.F. from G.C.T. conditioned medium was 
4,000 colonies / mg. Although these specific activities 
are somewhat lower than those reported by other workers 
(Nicola et al.,1979 ; Wu and Fischer, 1980) it may be that 
a comparison between CSF preparations from different 
laboratories is not possible because of the variation in 
bioassays. Both sources of C.S.F. used in the present study 
were found to be reliable and gave similar results on 
purification using hydrophobic chromatography and gel 
filtration. However, G.C.T. conditioned medium may prove to
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be a better source of C.S.F, if continuous cultures of the 
cells can be grown in serum - free medium. Gel filtration 
proved to be the most effective purification procedure for 
both sources of C.S.F.
The possible use of haematopoietic growth factors as 
therapeutic agents in the treatment of acute myeloid 
leukaemia by causing the differentiation of the malignant 
cells was proposed by Sachs in 1978. In 1983, Nicola e_t 
al . (1983) showed murine granulocyte-colony-stimulating 
factor (G-CSF) could induce the differentiation of the 
myeloid leukaemia cell line WEH1-3B. Recently these 
workers (Nicola ^  . 1985) have identified a human
analogue of this molecule and have shown it to be 
colony-stimulating factor (G.M.-C.S.F./?). It is therefore 
important large quantities of this factor are obtained to 
enable clinical trails to be carried out.A purified C.S.F. 
may also be useful in the treatment of immune disorders 
such as acquired immune deficiency syndrome, (A.I.D.S.). In 
1982, Motoyoshi and coworkers reported the first clinical 
trials of C.S.F. In this study they administered human 
urinary C.S.F. to patients with leukopenia due to cytotoxic 
drug administration or irradation and obtained some success 
in restoring leukocyte numbers in these patients.
The bioassay for colony-stimulating factor is complex 
and takes between four and fourteen days to complete. This 
presents difficulties during the purification and limits
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the assay for routine uses. In addition, the assay is 
difficult to standardise and is susceptible to various 
conditions such as inhibitory material in the sample to be 
assayed and lack of specificity. Radioimmunoassays are less 
time consuming, faster, easier to standardise, not 
susceptible to inhibitors and are specific. A pure 
preparation of colony-stimulating factor is nesscessary to 
establish a radioimmunoassay for this protein.
In the present study a colony-stimulating factor
(G.M.-C.S.F./?) from human placental conditioned medium 
7(Nicola et al., 1979) was radioiodinated and the 
feasability of a radioimmunoassay investigated. The 
antiserum was raised in New Zealand white rabbits against 
H.P.C.M.-IIb and examined by immunodiffusion (Figure 11) 
and Immunoelectrophoresis (Figure 12). The 
immunoelectrophoresis gave several precipitin arcs with the 
anti-C.S.F. against the H.P.C.M.-IIb and one precipitin 
arc with anti-C.S.F. against G.M.-C.S.F.a and one 
precipitin arc with the antiserum against G.M.-C.S.F^. 
Although this anti-C.S.F. inhibited colony formation in the 
C.S.F. bioassay the precipitin lines observed may be due to 
an antibody raised against a contaminating protein. Other 
workers have shown anti-C.S.F. preparations to be 
inhibitory in bioassays (Shadduck et al 1979) but it can 
not be said with certainty that the inhibition was due to 
the anti-C.S.F. antibodies alone. To rule out the 
possibilty of components of the rabbit serum being 
inhibitory in the bioassay it would be necessary to include
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a sample of rabbit serum in a bioassay prior to the 
commencement of the immunisation program.
In the preliminary binding studies the purest 
preparation of G.M.-C.S.F. was radiolabelled with 125 - I 
and reacted with various dilutions of anti-C.S.F. The 
radioiodination procedure used was that of Greenwood ^ et al., 
(1963). This method utilised chloramine-T and included 
dimethyl sulphoxide and polyethylene glycol 6000 to 
preserve biological activity. In the binding experiments 
the concentration of antiserum used was a 1:10 dilution of 
the neat preparation. This is the concentration of 
antiserum which bound 50% of a trace amount of 
radiolabelled G.M.-C.S.F. . Figure 14 shows a typical curve 
obtained when log G.M.-C.S.F. concentration was plotted 
against percent labelled polypeptide bound. From these 
preliminary studies it can be seen that a more highly 
purified C.S.F. preparation and/or a more specific antibody 
are required before a sensitive radioimmunoassay for C.S.F. 
can be developed.
To date there has been only one report of a 
radioimmunoassay for a human C.S.F. (Das e^ ^  .,1981) 
and there are many difficulties in adopting this approach.
A pure preparation of C.S.F. must be available in 
sufficient quantities to raise an antiserum and to provide 
suitable standards. The advent of hybridoma technology may 
permit a monoclonal antibody to be raised against an impure 
C.S.F. preparation and genetic engineering techniques may
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provide sufficient quantities of pure C.S.F. for use in 
immunoassays.
Radioimmunoassay has several disadvantages over other 
conventional methods of assaying biological material. The 
use of radioisotopes presents a small but significant 
hazard to workers and the environment. During the present 
study all work was carried out in specialised laboratories 
designated for radioisotope work. Radioiodine was used in 
fume hoods and the thyroid and femur monitored at weekly 
intervals. Disposal of radioactive material was carried out 
using procedures stipulated by the appropriate authorities. 
Other disadvantages of radioimmunoassay Include the use of 
expensive counting equipment and the limited shelf-life of 
reagents due to the relatively short half lives of some of 
the radioisotopes used.
Alternative labels have been sought in recent years. 
The most widely used of these labels are enzymes (Voiler 
et al . 1978; Wisdom, 1976). An enzyme-linked immunoassay 
has been established for a colony-stimulating factor 
C.S.F.-l (Chen ei^  a3^  .,1983). In the present study 
colony-stimulating factor from pokeweed mitogen stimulated 
spleen conditioned medium was labelled with horseradish 
peroxidase and the binding of this labelled growth factor 
to murine bone marrow cell membrane preparations studied.
Another problem associated with radioimmunoassay is i
that the immunologically reactive material may not be
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directly comparable to the biological activity. In 1970 
Lefkowitz e^ ^  . showed that radiolabelled 
adrenocorticotropic hormone binds to receptors extracted 
from adrenals. The finding led to the establishment of a 
variant of the competitive protein binding assay, the 
radioreceptor assay. Radioreceptor assays have the 
principal advantage over radioimmunoassays in that they may 
reflect, more accurately, the biological activity of the 
material. Moreover, competitive protein binding techniques 
which employ membrane receptors may be useful in 
investigating conditions in which an abnormal receptor can 
lead to disease. In the present study the binding of 
horseradish peroxidase labelled C.S.F. to bone marrow cell 
membranes was investigated.
Cell-surface receptors, located in or on the plasma 
membrane have been shown to exist for a number of 
biologically active molecules including hormones, growth 
factors and neurotransmitters (Kahn, 1976). The binding of 
these molecules to the receptor may trigger the desired 
physiological response via a number of intracellular 
events. On binding to the receptor one or more of the 
following internal events may take place: (1), The 
internalisation of the molecule and it's subsequent 
transport to the cell nucleus where, presumeably, a genetic 
template is uncovered and gene expression altered 
(Carpenter and Cohen, 1979). (2), Phosphorylation of 
intracellular proteins (Cohen, 1982; Carpenter e^ al^  .,
1979). (3), The synthesis of second messengers such as
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cyclic nucleotides (Rodbell, 1980 ; Ross and Gilman, 1980) 
and inositol lipids (Berridge and Irvine, 1984).
Receptor molecules, therefore, play a central role in 
biological processes. In the present study the binding of a 
haematopoietic growth factor, colony-stimulating factor, to 
it's putative target cells, bone marrow cells, was 
investigated. Colony-stimulating factor from pokeweed 
mitogen-stimulated mouse spleen conditioned medium was 
labelled with horseradish peroxidase and the binding of 
this labelled material to mouse bone marrow membranes was 
studied. Although a radioreceptor assay for C.S.F. has been 
reported by Das e^ al^  . (1980), there is no report of a 
receptor-bound assay for C.S.F. using enzyme-labelled 
colony-stimulating factor.
In order to establish that enzyme - labelled 
polypeptides could be used in place of radionuclide 
labelled molecules for membrane receptor binding studies 
the following experiment was performed : Glucagon was 
labelled with horseradish peroxidase and the binding of 
this material to a rat hepatocyte membrane preparation was 
investigated. It was demonstrated that horseradish 
peroxidase labelled glucagon binds to rat hepatocyte 
membrane preparations and that the specific binding of 
enzyme labelled glucagon exhibits a linear relationship to 
the concentration of membrane protein. There was no 
significant non-specific binding observed in these studies.
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Horseradish peroxidase labelled C.S.F. binds to bone 
marrow cell membranes and this specific binding exhibits 
linear relationship with membrane protein concentrations. 
This finding confirms the existance of membrane receptors 
for C.S.F. (Stanley, and Guilbert, 1981 ; Das e^ al^  .
1980). Isolated membranes were used in this study because 
they offer the advantage of stability on storage at -20 C 
and the receptors are more concentrated than in intact 
cells (Gardner, 1979).
Our understanding of the physiological events in 
haematopoiesis will be greatly enhanced by the study of 
membrane receptors for C.S.F. Different stem cell 
populations may respond to different colony-stimulating 
factors by possessing a membrane bound receptor for the 
particular C.S.F. involved. Other stem cells may respond to 
more than one subclass of haematopoietic growth factor.
In addition to leading to the development of simple 
assays for C.S.F. and it's receptor, the molecular 
mechanisms which underlie human disease can be investigated 
using receptor-bound studies.Downward et_ ^  . (1984) 
have proposed that an abnormal epidermal growth factor 
receptor may lead to cancer. Antibodies directed against a 
receptor for a growth factor such as C.S.F. may lead to 
disease (Belcher, 1979). It is interesting, therefore, to 
spectulate on the role of receptors for haematopoietic 
growth factors in diseases like leukaemia.
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For example, the Friend leukaemia cell line is a 
mouse erythroleukaemia which does not respond to 
erythropoietin (Marks ej^  al_ ., 1974) and, therefore, 
this leukaemia may be due to an abnormal receptor for 
erythropoietin. The use of immunoassay to measure the 
amounts of C.S.F. in serum from leukaemia patients and the 
use of receptor assays to study membrane receptors for 
C.S.F. on leukaemia cells may greatly increase our 
understanding of leukaemia and related disorders. Indeed, 
it may be possible to use enzyme labelled C.S.F.*s to 
visulise receptors on cells using cytochemical techniques.
Leukaemia is a group of neoplastic blood disorders 
resulting in the uncontrolled proliferation and 
differentiation of blood cell precursors. The disease is 
classified by the clinical course of the disease (acute or 
chronic) and by the type of cell involved (Table 5). 
Although the cause of leukaemia is unkown it now seems 
likely that this disease may arise due to the expression of 
an abnormal gene. The abnormal gene may result from 
radiation damage to DMA, chemical damage to DMA, somatic 
mutation or the integration of foreign DMA into the genome 
by oncogenic viruses
In 1911 Rous discovered a RNA virus which gave rise to 
tumours in chickens. This retrovirus became known as the 
Rous sarcoma virus (R.S.V.) and since its discovery a 
number of viruses which cause cancer in a variety of 
vertebrates have been recognised (Bishop, 1983). Two
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viruses which cause cancer in man have been recognised.
One of these is a DNA virus, the Epstein-Barr virus, which 
causes glandular fever in normal hosts but which can cause 
Burkitt's lymphoma in patients with poor T-cell 
immunoregulation due to Plasmodium falciparum malaria 
(Whittle ^  ^  . 1984). The second human active
oncogenic virus is the Human T-cell leukaemia virus-type I 
which causes adult T-cell leukaemia in restricted areas of 
Japan and in some other individuals (Poiesz et. al^  ., 
1980, Poiesz e^ ^  ., 1981, and Haynes ^  ^  .,
1983).
Oncogenic viruses may possess a DNA genome or a RNA 
genome. The DNA viruses include the SV40 virus which 
causes tumours in monkeys and the Epstein-Barr virus. The 
RNA tumour viruses include the Rous sarcoma virus and the 
human T-cell leukaemia virus - type I. The mechanisms 
whereby these tumour causing viruses act are gradually 
becoming unveiled. In 1969 Huebner and Todaro proposed 
their oncogene hypothesis. They postulated the existance 
of oncogenes in normal cells and their activation by 
viruses, radiation or carcinogens to produce cancer. They 
further postulated that these cellular oncogenes could be 
transduced by viruses and so become part of the viral 
genome.
The discovery of reverse transcriptase led Temin 
(1971) to postulate the protovirus theory.Temin proposed 
that normal cells contain potential oncogenes which could
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become viral or cellular oncogenes by somatic mutation and 
the action of reverse transcriptase.
The first viral oncogene to be biochemically defined 
was the src gene of the Rous sacroma virus (Duseberg and 
Vogt, 1970; Martin and Duesberg, 1972; Lai ^  ^  •
1973). The src gene was shown to be necessary for the 
viruses ability to cause tumours but was not essential for 
the survival of the virus. Since the recognition of the 
src gene about 16 other oncogenes have been characterised 
(Bishop, 1983). In addition to these oncogenes being 
present in viruses (v - one) they have been shown to exsist 
in normal cells of all species studied, including tumours, 
as part of the normal genome (Scolnick et ^  1973; 
Scolnick and Parks, 1974; Tsuchida ej^  a3^  ., 1974; 
Scolnick, 1981; Stehelin ^  al^  ., 1976; Frankel and 
Fischinger, 1976). The positions of some of these cellular 
oncogenes (c-onc) on human chromosomes are shown in Figure 
19.
Some of the proteins encoded by these oncogenes have 
recently been identified. Waterfield el^  ^  ., (1983) 
have shown that platelet-derived growth factor is encoded 
by c-sis. The oncogenes c-fos and c-myc have been shown to 
be nuclear proteins. Downward e^ ., (1984) have
shown the erb-B product to be a portion or sub-unit of the 
epidermal growth factor receptor and McGrath ^  ^  .,
(1984) have provided evidence that the ras product acts in 
a similar fashion to the G protein which regulates adenyl
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cyclase.
Phosphorylation and dephosphorylation reactions are 
present in the switching on and off of many cellular and 
physiological processes including cell proliferation and 
differentiation. In particular, the phosphorylation of 
tyrosine residues seem to be prevalent in mitogenic 
responses. Many tumour causing viruses have been shown to 
phosphorylate tyrosine residues and epidermal growth factor 
has been shown to activate a protein kinase which 
phosphorylates tyrosine residues of cellular proteins 
(Ushiro and Cohen, 1980).
It is interesting to speculate on the role of 
colony-stimulating factors and their receptors in 
haeraatopoiesis in the light of this new information on 
oncogenes and growth factors. However, the currently 
available sources are inadequate for the purification of 
sufficient quantities of these growth factors to enable any 
worthwhile investigations to be undertaken. Currently, the 
most promising possibility is the production of C.S.F. by 
genetic engineering techniques.
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Table 5; The classification of the human leukaemias.
Classification of the Leukaemias
Acute Leukaemias
Acute myeloblastic (poorly differentiated)
M2 Acute myeloblastic (well differentiated)
M3 Acute promyelocytic
M4 Acute myelomonocytic
M5 Acute monocytic
M5 Erythroleukaemia
Acute megakaryoblastic
Acute lymphoblastic : common (non-T, non-B, cALL positive)
null - ALL (non-T, non-B)
Thy. - ALL 
B -ALL
Chronic Leukaemias
Chronic myelocytic 
Chronic lymphocytic 
Hairy cell leukaemia 
Prolymphocytic 
Dysmyelopoietic syndromes
Table 5
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Figure 19: The position on human chromosomes of the cellular
oncogenes; c-myc (Neel et al., 1982), c-abl (de Klien et al., 1982), 
c-ets (de Taisne et al., 1984), c-myb (Harper et al., 1983) and 
c-sis (Dallas-Fayera, et al., 1981).
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Figure 20; Some possible roles of C.S.FZs in leukaemia.
C.S.F. producing cell
C.S.F
Target cell
CELL PROLIFERATION
Possible defects in leukaemia
abnormal C.S.F. 
abnormal receptor 
abnormal internal events 
abnormal inhibitor 
abnormal gene 
excess C.S.F. 
low inhibitors
Figure 20
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GROWTH OF CHICK MYOCARDIAL CELLS IN SERUM - FREE CULTURE
INTRODUCTION
INTRODUCTION
The study of mechanisms which control cellular 
division and differention has been facilitated by the 
introduction of cell culture techniques (Paul , 1972) and 
cell culture has become an increasingly more important 
laboratory tool used in a wide variety of disciplines 
including embryology , laboratory medicine and 
biotechnology.
The growth of muscle in cell culture has provided 
biologists with an interesting model for cellular 
differentiation. There are three principal types of muscle. 
These are, smooth muscle, cardiac muscle and skeletal 
muscle. Most information regarding the growth and 
differentiation of muscle is available for skeletal muscle. 
Here, the myoblasts fuse to give rise to myotubes which, in 
turn give rise to the myofibrils.
Cardiac muscle has been, successfully, grown in cell 
culture (DeHaan, 1967). These cultured cells are capable of 
spontaneous activity and can be observed to beat (DeHaan, 
1967).Cardiac cells in culture have applications in 
pharmacology to monitor the effects of drugs on the heart 
(Acosta ej^  a^ ., 1974) and in cardiology to monitor the 
effects of electrical countershock treatment (Jones ej^
Ml *, 1978).
The use of cultured chick embryonic heart cells to 
study the effects of electrical field stimulation led Jones
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et al • (1976) to develop adult-type cardiac cell 
culture. These workers found it easier to insert 
microelectrodes into the adult type cells than into the 
embryonic heart muscle cells (Jones et al., 1978). They 
harvested myocardial cells from 8 day - old chick embryos 
and cultured the cells, first, in Leibowitz L-15 tissue 
culture medium containing 10% (v/v) foetal calf serum for 
two days and then in Leibowitz L-15 ( without histidine ) 
containing methionine and 0.1% (v/v) foetal calf serum. In 
this medium the cells differentiate into cells exhibiting 
adult-type morphology.
The culture of cardiac muscle cells may provide a 
useful tool for the study of cellular proliferation and 
differentiation. In studying cells in culture it is 
desireable to define the culture conditions. Most mammalian 
and avian cell cultures require serum, such as foetal calf 
serum, to support their growth. Serum is a complex mixture 
of components and probably provides, hormones, growth 
factors, cell attachment factors, transport proteins plus a 
mixture of different nutrients. The development of a 
serum-free growth medium would, therefore, help to define 
the culture conditions.
In the present study, a serum-free cell culture 
medium was developed for chick myocardial cells. The 
defined medium contained Leibowitz L-15, antimycotic 
solution, L-glutamine, sodium pyruvate, sodium selenite, 
phosphatidyl choline, glucagon, somatotropin and insulin.
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In this medium the embryonic cells were observed to 
differentiate into adult - type myocardial cells.
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MATERIALS AND METHODS
MATERIALS AND METHODS
BASIC PROCEDURE FOR THE CULTURE OF CHICK MYOCARDIAL CELLS
All culture work was carried out under a perspex hood 
swabbed down with 70 % (v/v) ethanol. Pipettes and 
dissection equipment were flamed before use. The work 
surface and dissection instruments were sterilised with 70% 
(v/v) ethanol.
The serum-containing medium was prepared by adding 1ml 
of L-glutamine 1ml of antibiotic / antimycotic solution, 
and 11ml of foetal calf serum to 100 ml Leibowitz L-15 
medium. Additional L-glutamine was added after 
approximately four days. All these solutions were obtained, 
already prepared, from GIBCO, Paisley, Scotland.
An eight day old fertilised chicken egg (Wright Chicks 
Ltd., Newtownards, Northern Ireland) was placed in a 50 ml 
beaker and soaked with 70% (v/v) ethanol. Scissors were 
soaked in 70% (v/v) ethanol and flamed. The egg was flamed, 
an incission made, and the top of the egg removed. The 
embryo was removed, by forceps, and placed on a 70 mm 
plastic petri dish (Nunc, Denmark) containing 4 ml culture 
medium.The head of the embryo was removed and the beating 
heart was then carefully dissected without excess tissue. 
The heart was transferred to a second 70 mm plastic culture 
dish. The embryo was then discarded, and a further five 
hearts obtained in thi^l.manner.The hearts were added to a
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vial tube to which sufficient 0.05% (w/v) trypsin solution 
had been added to cover the contents of the tube. The vial 
tube was incubated at 37®C for 10 minutes with constant 
stirring on a magnetic stirrer (M.S.E., Crawley, England) 
at 5 cycles per second. The supernatant became cloudy. This 
supernatant was discarded, and 1 ml 0.05% (w/v) trypsin 
solution were added and the trypsinisation procedure 
repeated. This supernatant was aspirated and added to a 
centrifuge tube containing 2ml of culture medium. This 
procedure was repeated until the supernatant became clear.
The contents of the centrifuge tube were centrifuged for 
ten minutes at 2500 x g at 4*C. The supernatant was Iaspirated and the myocardial cells resuspended in ]iapproximately 0.5 ml fresh culture medium. Two drops of jicell suspension were added to each of twelve 70mm plastic
Ipetri dishes (two dishes per heart). The culture medium was |
changed daily. To prevent fibroblast growth the j
concentration of foetal calf serum was reduced from 10% to iJ!0.1%. The cultures were examined using an inverted phase '
contrast microscope (Wild, Heerburg, Switzerland). j
!
ESTABILISHMENT OF A SERUM FREE CELL CULTURE MEDIUM FOR
CHICK MYOCARDIAL CELLS I
i
Serum was gradually replaced with, sodium pyruvate, - 1
sodium selenite, bovine serum albumin, transferrin, IIphosphatidyl choline, glucagon, somatotropin and insulin at i
various concentrations. All chemicals were of the purest jj
grade available and were obtained from Sigma Chemical Co. I
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Ltd., St. Louis, MO., U.S.A. Culture and examination of the 
cells were the same procedures described for 
serum-containing cultures.
PRETREATMENT OF GLASS COVERSLIPS
In some experiments the cells were grown on glass 
coverslips to facilitate staining and light microscopic 
examination.The glass coverslips were placed in L-15 medium 
containg foetal calf serum (10%), and incubated for 24 
hours at room temperature. These cover slips were then 
washed in sterile water to remove excess medium and allowed 
to dry in an incubator at 37®C.
STAINING OF CELLS FOR LIGHT MICROSCOPY
A coverslip containing a monolayer of cells was 
submerged into Gendre fluid for approximately 15 seconds to 
fix the cells, and washed twice with distilled water. The 
cells were then immersed in toluidine blue, pH 9.2, for 30 
seconds, and washed (x2) in distilled water another two 
times. The stained cells were then mounted using D.P.X. 
mounting medium. The stained preparation was then examined 
under a Watson Nulux 70 light microscope.
PREPARATION OF CELLS FOR TRANSMISSION ELECTRON MICROSCOPY
Primary fixation of the cells was carried out in 2.5% 
(w/v) glutaraldehyde, 2% (w/v) paraformaldehyde and 3%
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(w/v) sucrose in 0.1m sodium cacodylate buffer, pH 7.2, at 
room temperature for two hours.The cells were then washed 
for one hour, at room temperature, in 0.1m sodium 
cacodylate buffer, pH 7.2 containing 3% (w/v) sucrose. 
Secondary fixation was performed at room temperature for 
one hour in 1% (v/v) osmium tetroxide on 0.1m sodium 
cacodylate buffer, pH 7.2.The cells were dehydrated by 
being taken from 70% (v/v) alcohol, 90% (v/v)alcohol to 
absolute alcohol. The cells spent one hour in each of these 
solutions, and whilst in the 100% alcohol they received 
three changes over the one hour period. The cells were 
embedded in resin by incubating in; absolute ethanol, 50% 
absolute ethanol/50% Spurr resin, 25% absolute ethanol/75% 
Spurr resin, and in 100% Spurr resin.The cells were 
polymerised by incubating at 70^C for 24 hours. Silver 
sections (60-90nm) were cut on the L.K.B. Nova 
Ultramicrotome (L.K.B., Bromma, Sweden) using glass 
knives.The sections were double stained in uranyl acetate 
and lead citrate. The stained sections were then examined 
using a Jeol Transmission electron microscope 1005 (Jeol, 
Tokyo, Japan).
95 I
RESULTS
RESULTS
BASIC TECHNIQUE FOR THE CULTURE OF CHICK MYOCARDIAL CELLS
Chick myocardial cells grew readily in 
serum-containing cell culture medium. The average seeding 
density of the cells was 670 per dish. The cells formed a 
monolayer within 24 hours of seeding and areas of beating 
cells could be seen.The cells could be seen to 
differentiate after 24 hours in culture.
ESTABLISHMENT OF A SERUM-FREE CELL CULTURE MEDIUM FOR CHICK 
MYOCARDIAL CELLS
After replacing serum with various concentrations of 
chemicals which may be required by cells in culture, it was 
found that the cells grew in Leibowitz L-15 medium 
containing, 0.0011% (w/v) sodium pyruvate, 0.00000173%
(w/v) sodium selenite, 0.004% (w/v) bovine serum albumin, 
0.00001% (w/v) human transferrin, 0.001% (w/v) phosphatidyl 
choline, 0.000032% (w/v) glucagon, 0.0001% (w/v) 
somatotropin and 0.005% (w/v) insulin.The cells grew 
readily in this medium. They formed a monolayer after 24 
hours in culture and showed spontaneous activity. The cells 
were well differentiated within 24 hours and were 
indistinguishable from cells grown in serum-containing 
cells.
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STAINING OF THE CELLS FOR LIGHT MICROSCOPY
Staining of the cells in culture enabled the cultures 
to be assesed more readily than by observing cultures under 
the inverted phase contrast microscope. A few fibroblasts 
were noted in the serum-containing cultures but their 
growth was inhibited in serum-free cultures and in cultures 
with reduced serum content.
ELECTRON MICROSCOPY OF CHICK MYOCARDIAL CELLS IN CULTURE
The cells from serum-free culture were 
indistinguishable, by transmission electron microscopy, 
from cells grown in serum-containing medium. The 
ultrastructural features shown by electron microscopy are 
given in Figures 21 - 25. Figure 21 shows a coated pit and 
glycogen granules. Intercellular attachments may be seen in 
Figure 22. Longitudional sections, and transverse sections 
of muscle fibres can be seen in Figure 23. Figure 24 shows 
muscle striations with a Z line and Figure 25 shows the 
thick and thin filaments of cardiac muscle.
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DISCUSSION
DISCUSSION
Serum in cell and tissue culture provides the growing 
cells with hormones, growth factors, attachment factors, 
transport proteins, detoxifying agents,and trace nutrients. 
The development of serum-free culture is desireable if we 
are to adequately describe the molecular mechanisms which 
regulate cell growth in vitro . See: Barnes and 
Sato,1980a,b.
Cardiac muscle cells in culture have been used to 
monitor the probable effects of drugs on heart tissue 
(Acosta elt ^  .,1974) and to study the effects of 
defibrillators on the heart muscle (Jones ei^  ^  .,1978). 
The development of defined culture comditions for these 
cells may make the interpretation of these studies easier.
Early attempts to define the molecules, in serum 
responsible for the growth of cells in culture involved 
trying to isolate these factors from serum. These studies 
proved unsuccessful (Temin, 1972). For a reveiw of serum 
factors in cell culture see Gospodarowitz and Moran, 1976. 
However, Sato and other workers used a different approach. 
These workers replaced serum with various substances, and , 
in this way were able to develops serum-free media (Barnes 
and Sato, 1980a,b.
In the present study a serum-free cell culture medium 
was developed for chick heart cells by adding various
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substances to the medium in place of serum. This empirical 
approach was successful in estabilishing a defined growth 
medium for these cells. The cells grew only on the defined 
medium reported in the previous section.The cultured cells 
were examined by light and transmission microscopy. The 
ultrastructural features are given in the results section 
and a selection of micrographs displayed in Figures 21-25.
These cultured cells were seen to beat spontaneously 
and may provide a useful model for further studies.lt may 
be a useful line of study to investigate the role of 
polypeptide growth factors which might be responsible for 
the growth and/or differentiation of heart cells in 
culture. In the present study, cardiac cells grew and 
differentiated in serum-free culture. It would be likely 
that such growth factors (if they exist) are produced by 
the cardiac cells themselves.
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Figure 21; Electrom micrograph,of cultured myocardial: cells 
grown in serum-free medium,showing a coated vesicle (CV) and glycogen 
granules (GL). Magnification x 100,000.
Figure 21
— lOO —
Figure 22: Electron micrograph of chick myocardiàlé cells
grown in serum-free medium. Intercellular attachments can be 
seen. Magnification x 30,000,
Figure 22
_ lOL.
Figure 23; Low magnification electron micrograph showing 
longitudional striations (LS) and transverse sections (TS) of 
muscle from chick myocardial cells grown in serum-free culture. 
Magnification x 5000.
Figure 23
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Figure 24; Electrom micrograph of chick myocardial cells grown 
in serum-free cell culture medium showing muscle striations with 
Z line (Z). Magnification x 20,000.
Figure 24
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Figure 25: An electron micrograph of chick myocardial cells grown
in culture showing the deposition of thick and thin muscle filaments. 
Magnification x 25,000.
Figure 25
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